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Abstract
Proper brain function involves many processes carried out in or at membranes. The
many cells and organelles in the brain are responsible for processes such as adenosine
triphosphate (ATP) production, protein cleavage, transfer of electric signals along
neurons (brain cells) and membrane vesicle formation, which are all either facilitated
by lipid membranes or involve lipid membranes directly. In diseases affecting the brain
such as Alzheimer’s disease, symptoms may arise from perturbations in the normal
functioning of some of these processes. The peptide amyloid-β has long been associated
with the disease, however the link between the peptide and the origin of symptoms is
poorly understood. An emerging hypothesis is that monomeric and oligomeric forms of
the peptide interact with neuronal membranes, resulting in perturbations in the bilayer
structure and in the dynamic processes which take place in the bilayer.
Using X-ray and neutron scattering techniques, the structure and dynamics of model
lipid membranes and the changes which arise in the presence of amyloid-β peptide
fragments have been studied. Monomers of the peptide fragment amyloid-β22−40
were found to intercalate into an anionic lipid bilayer. Through quasi-elastic neutron
scattering, dynamics of bilayer lipids were observed. The presence of 1.5 mol% of the
peptide results in a decrease in the diffusion coefficients for lipid centre of mass motion
on the nanosecond time-scale, as well as lipid tail dynamics on the picosecond scale
at 30◦C. On the other hand, in the gel-phase of the lipid, at 15◦C, an increase in the
diffusion coefficients for both of these processes was observed.
A series of samples with various cholesterol content and either the amyloid-β22−40
peptide fragment or the amyloid-β1−42 full length peptide was characterized using
X-ray diffraction. Structural details, including the peptide position, were modelled
and compared to electron density plots obtained from the diffraction experiments.
The amyloid-β22−40 peptide was found to populate two positions, on the surface and
embedded in the bilayer. The amyloid-β1−42 peptide embeds itself into the membrane,
is modelled by a single population for high cholesterol levels (40 mol% cholesterol).
The design and commissioning of the BerILL humidity chamber, a sample
environment with precise temperature and humidity control compatible with neutron
scattering experiments is presented. The project goal of achieving high and stable
humidity was achieved, the presented humidity chamber allows for precise control
of temperature and humidity up to 99.9% relative humidity. Temperature and
humidity control are essential for experiments with biological samples, and can be
easily and reliably controlled with the chamber. The BerILL humidity chamber allows
for increased efficiency during neutron experiments and can replicate physiological
conditions experimentally.
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Zusammenfassung
Die Funktion des Gehirns hängt von vielen Prozessen ab, die an Membranen
ausgeführt werden. Dabei sind diverse Zellen und Organellen für verschiedene Prozesse
verantwortlich, wie z. B. die Herstellung von Adenosintriphosphat, Proteinspaltung,
Signaltransfer an Neuronen und Vesikelbildung. Die Lipidmembrane ermöglichen
und beeinflussen diese Prozesse über ihre Struktur. Krankheitssymptome, wie z. B.
die der Alzheimer’schen Demenz, können durch eine Störung der normalen Prozesse
hervorgerufen werden. Das Peptid Amyloid-β wird seit vielen Jahren mit der
Alzheimer’schen Demenz in Verbindung gebracht, aber die Verbindung zwischen dem
Peptid und der Herkunft der Symptome bleibt unklar. Eine neue Hypothese besagt,
dass Wechselwirkungen von Mono- oder Oligomeren des Amyloid-β mit neuronalen
Zellmembranen zu Veränderungen der Membran-Doppelschichtsruktur führen und
Störungen dynamischer Prozesse in den Membranen verursachen können.
Mit Methoden der Röntgen- und Neutronenstreuung wurden die Struktur und
Dynamik von Modellmembranen und Änderungen durch den Einfluss des Peptids
Amyloid-β auf die Modellmembranen untersucht. Es konnte gezeigt werden,
dass Monomere des Peptidfragments Amyloid-β22−40 in anionische Lipidmembranen
eingebaut werden. Mittels quasielastischer-inkohärenter Neutronenstreuung wurde die
Dynamik von Lipidmembran untersucht. Ein Anteil von 1,5mol% Amyloid-β22−40 in
einer Lipidmembran bei 30◦C verursacht eine Verringerung der Diffusionskoeffizienten
sowohl der Schwerpunktbewegung der Lipide im ns-Bereich als auch der Dynamik der
Fettsäurereste im ps-Bereich. Andererseits wird in der Gelphase der Lipidmembran bei
15◦C ein Anstieg der Diffusionskoeffizienten beider Prozesse beobachtet.
Eine Serie von Lipidproben mit unterschiedlichem Cholesteringehalt und
eingelagerten Peptiden Amyloid-β1−42 und Amyloid-β22−40 wurde Mittels
Röntgendiffraktion charakterisiert. Strukturdetails einschließlich der Lage der
Peptide wurden modelliert und mit den experimentellen Elektronendichteprofilen
verglichen. Für das Peptid Amyloid-β22−40 wurden zwei Positionen gefunden, eine auf
der Oberfläche der Membran, eine zweite in der Membran eingelagert. Das Peptid
Amyloid-β1−42 ist teilweise in die Membran eingelagert und ist in einer 40mol%
Cholesteringehaltige Membrane durch eine einzelne Position modelliert.
Der Entwurf und die Inbetriebnahme der BerILL Feuchtekammer wird beschrieben.
Unser Entwicklungsziel, stabile und hohe relative Feuchte zu produzieren, wurde
erreicht. Die vorgestellte Feuchtekammer erlaubt die präzise Kontrolle von Temperatur
und Luftfeuchtigkeit bis zu 99.9% relativer Feuchte. Die Parameter Temperatur
und Feuchte sind essentiell für Experimente mit biologischen Proben und durch die
BerILL Feuchtekammer wird die Effektivität von Neutronenstreuexperimenten erhöht
und Experimente unter physiologischen Bedingungen ermöglicht.
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1 Introduction
1.1 Motivation
The lipid membrane is one of the most important structures in biology. The membrane
structure facilitates the compartmentalization of cells and organelles, creating barriers
between aqueous compartments and their surroundings. Without these barriers,
complex life would not be possible. Early models of the lipid membrane describe it as
a passive medium which acts as a host to the more important biological entities such as
protein complexes [1], but more recently the focus has shifted towards understanding
the membrane to reveal biological function [2]. The composition of a membrane is
closely linked to the membrane’s properties and its functionality [3]. Changes in
membrane composition, and the interactions of peptides or proteins with membrane
lipids are known to modify these properties, and may lead to detrimental side-effects
[4].
The proper functioning of a complex organ like the brain involves many processes
carried out at membranes. Processes such as adenosine triphosphate (ATP) production,
protein cleavage, transfer of electric signals along neurons (brain cells) and membrane
vesicle formation, which are all either facilitated by lipid membranes or involve lipid
membranes directly [5]. In particular, in diseases affecting the brain such as Alzheimer’s
disease, symptoms may arise from perturbations in the normal functioning of some of
these processes [6, 7, 8, 9, 10, 11, 12, 13].
Alzheimer’s disease has been studied for over 100 years, with the first reported link
between the symptoms of dementia and brain physiology in 1907 [14]. The initial
hypothesis was that symptoms of the disease were related to overproduction of certain
proteins, leading to proteinous plaques in the extracellular regions of the brain [15].
Although this hypothesis has been studied for many years, no clear explanation of the
origin of the symptoms exists. A new hypothesis has been proposed, connecting the
symptoms to perturbations in the lipid membrane caused by membrane intercalated
monomers of the amyloid-β peptide [16, 17, 18, 19, 20].
Changes in the interactions of peptides or proteins with a membrane are often
associated with diseases. Although the exact mechanism of action of Aβ toxicity
remains obscure [21], there is strong evidence that Aβ peptides can penetrate
membranes [22, 23], leading to permeabilization [24] and to pore formation [25].
Changes in the complex bilayer structure or dynamics may affect the rate and feasibility
of essential processes carried out in the cell membrane [6].
In particular, membrane dynamics are of special importance when considering the
efficiency of the secretases responsible for cleavage of the amyloid-β precursor APP
1
1 Introduction
(amyloid precursor protein). A perturbation of the lipid diffusion rate can lead to a
change in the behaviour of the β and γ secretases, causing an autocatalytic increase
in the formation of neurotoxic amyloid-β species, further stimulating toxic peptide
production [7, 18, 8]. Neuronal cells, especially their synapses, are rich in mitochondria
which produce ATP for the energy demanding synthesis and release of transmitter
molecules involved in cognitive functions. Thus, amyloid-β induced changes in lipid
dynamics of mitochondria can lead to decreased ATP production and eventually cell
death [9, 10]. Furthermore, at the synapses, essential fusion and vesicle formation
processes will be affected by changes in lipid dynamics, leading to complications in
signal transduction [11, 12, 13, 26]. Therefore, a clear picture of the membrane
dynamics and the changes which occur in the presence of the neurotoxic peptides is
essential to understand this complex disease.
Model lipid membranes can be used to create a system which is simple enough to
describe quantitatively and yet realistic enough to extract meaningful parameters and
gain insight. The goal is to produce quantitative data which will then shed light onto
complex biological structure or processes. The model systems used are typically studied
in controlled temperature and humidity environments which can replicate physiological
conditions.
The dynamics of membrane lipids over various length and time-scales can be
explored with a variety of techniques. Molecular dynamics (MD) simulations shed
light on the motions of lipids in the fs to ns time-range. MD simulations predict
long-range diffusion with relaxation times slower than a nanosecond, sub-diffusive
(restricted) dynamics in the picosecond range, and ballistic dynamics occurring in the
sub-picosecond range [27, 28]. The observation of lipid dynamics over a large time-range
is experimentally accessible through the use of quasi-elastic neutron scattering. By
tuning the experimental parameters (instrumental resolution) of a QENS spectrometer,
a specific time-range can be observed, allowing one to isolate and analyze motions
of interest [29]. In particular, nanosecond dynamics can be measured by high
energy resolution backscattering spectrometers [30, 31, 32, 33], while faster picosecond
dynamics can be observed with low energy resolution time-of-flight spectrometers
[34, 35, 36, 37]. The nanosecond dynamics can be compared to other techniques such
as fluorescence [38, 39, 40] or NMR (nuclear magnetic resonance) [41, 42]. Recent
quasi-elastic neutron scattering experiments from Busch et al. and Sharma et al. have
shown that small molar amounts of membrane present molecules such as cholesterol
[43] or melittin [33] can have a considerable effect on membrane lipid dynamics, which
sets the stage for dynamic measurements with amyloid-β peptides.
In a recent review by Yang et al. [18], the effect of Aβ peptide fragments and
other molecules (such as cholesterol) on the diffusion rate of lipids in the membrane
is presented. Amyloid-β peptide fragments perturb the structure of the bilayer [23]
and can change the picosecond lipid dynamics, as recently demonstrated by our group
[44, 45]. In particular, the first measurements by Buchsteiner et al. showed the effect
of the short, primarily hydrophobic, Aβ25−35 peptide on the picosecond dynamics of a
lipid bilayer, indicating decreased translational lipid dynamics with peptide presence in
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the gel and fluid phases [44]. Further investigations compared the effect of Aβ25−35 and
Aβ22−40, the latter being a peptide fragment with a length and hydrophobicity similar
to that of a DMPC (1,2- dimyristoyl- sn- glycero- 3-phosphocholine) lipid molecule, at
47◦C. A slowing of local lipid dynamics was observed in the presence of both peptides
well into the fluid phase [45].
To better understand the effect of peptides in the lipid bilayer, experiments on
different peptide fragments in increasingly complex systems are necessary. In this
thesis, the structural and dynamic changes to a lipid bilayer exposed to the Aβ22−40 and
Aβ1−42 peptides were explored in an anionic lipid bilayer, as well as a cholesterol rich
lipid bilayer. These experiments shed light on the complex interaction between lipids
and proteins, as well as push forward the understanding of the molecular processes
behind Alzheimer’s disease. The development and commissioning of a new humidity
chamber which can be used for future biophysics experiments is also presented.
1.2 Biological membranes
Many different cell types are present in complex organisms. Each cell has specific set
of physiological characteristics which allow it to perform the essential tasks vital to
the survival of the organism. The compartmentalization, not only of individual cells,
but also the organelles which the cells contain, is achieved using membranes. These
membranes consist of a variety of biological molecules including lipids, proteins, sterols
and sugars. The composition of a biological membrane varies drastically depending
on the particular cell or organelle and the function it must perform. Membranes are
permeable to certain ions and molecules, allowing passive diffusion through osmosis
to control the cell’s contents. Other ions and molecules must be actively transported
through membranes using protein complexes, building gradients across the membrane
[3, 4, 5].
1.2.1 Lipids
For the majority of cells, the membrane is composed of primarily lipids. Eukaryotes
in particular spend enormous amounts of resources synthesizing thousands of different
types of lipids. In fact, approximately 5% of the genetic information in eukaryotes is
used for creating and maintaining lipids [46]. Generally, lipids are small hydrophobic
or amphiphilic (containing hydrophobic and hydrophilic parts) molecules which
self-assemble into a variety of conformations depending on the solvent in which they
exist. With water as the main solvent in the vast majority of biological systems, lipids
tend to group into structures to shield the hydrophobic parts from the surrounding
water, as is seen in Figure 1.1. Depending on the type of lipid, and the concentration
of this lipid in the solvent, structures such as micelles, liposomes or bilayers can form.
In most biological systems a two molecule thick bilayer with a hydrophobic core is
common, with the hydrophobic tails of the lipid together in the centre. The human
body is composed of approximately 1013 cells [47], typically compartmentalized by a
3
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Figure 1.1: a) A DMPC lipid molecule chemical structure and simplification to a generic
phospholipid with its hydrophilic head-group (blue) and two hydrophobic
tails (yellow) and a water molecule chemical structure and cartoon (red). b)
When exposed to water, many phosopholipids self-assemble into a bilayer
formation, to decrease contact between the hydrophobic and hydrophilic
components. c) Depending on the properties of a single lipid, higher
structures such as vesicles (shown as a slice-through) may form. DMPC
chemical structures from Avanti Polar Lipids [48].
two molecule thick bilayer. These thin features extend to cover a vast surface area,
approximately 100 km2 for humans [2].
In 1972, the fluid mosaic model presented by Singer and Nicholson first described the
bilayer as a two-dimensional liquid with proteins freely floating within [1]. This model
has since been improved and modified. In the past 40 years, the role of the bilayer has
shifted from a passive environment in which biological processes occur to an important
part of cell function [49].
In biological membranes, various types of lipids are present, including glycerolipids,
sphyngolipids, phospholipids and sterols [50, 51]. Glycerolipids contain a mono-,
di- or tri-substituted glycerol and function as energy storage in the fat molecules of
animal tissues. They are found in membranes and in concentrations up to 8 mass%
[52]. Sphingolipids contain an amino alcohol called sphingosine with a hydrophobic
chain consisting of 16 to 26 carbons and are found primarily in the liver and in red
blood cells in concentrations of up to 19 mass% [53]. Phospholipids make up to
40 mass% of the membrane in mammalian cells [54]. Phosphate (PO4) groups are
found in the hydrophilic head-group of the phospholipid, giving the molecule its name.
Phospholipids, due to their high membrane concentration, have a large influence on the
membrane’s structure and behaviour [4, 55]. Sterols also make up a large percentage of
membranes, and are characterized by their four-ring core structure [56]. Cholesterol in
particular is found in the membranes of eukaryotic cells, and will be discussed in more
detail in Section 1.4.1.
A phospholipid can be further categorized by describing the features of the
hydrophilic head-group and hydrophobic tails. These classifications are based on the
charge of the head-group and the length and degree of unsaturated carbons in the
tails. Some common lipid head-groups include the phosphatidylserine (PS) head,
with negative charge, and the zwitterionic (containing two counteracting charges)
4
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phosphatidylcholine (PC) and phosphatidylethanolamine (PE). The acyl-chains of the
phospholipid tails typically range from 12 to 24 carbons, and may contain from 0
(fully saturated) to 6 (polyunsaturated) carbon-carbon double bonds. These tails are
described with the m:n format, with m representing the number of carbons in a chain,
and n representing the number of double bonds. In the remainder of this document, the
phospholipids will be referred to using the general term lipids. Table 1.1 lists a selection
of lipids which are commonly used in biophysical experiments. The bold entries have
been used for experiments in this thesis.
Properties of commonly used lipids
Name Abbrev. Components Chain Mw Transition
length (g/mol) temp. (K)
1,2-dimyristoyl-sn-glycero DMPS C35H65NO10PNa 14:0 701.844 308
-3-phospho-L-serine
1,2-dipalmitoyl-sn-glycero DPPC C40H80NO8P 16:0 734.039 314
-3-phosphocholine
1,2-distearoyl-sn-glycero DSPC C44H88NO8P 18:0 790.039 328
-3-phosphocholine
1,2-dioleoyl-sn-glycero DOPE C41H78NO8P 18:1 744.034 283
-3-phosphoethanolamine
1,2-dioleoyl-sn-glycero DOPS C42H77NO10PNa 18:1 810.025 262
-3-phospho-L-serine
1,2-dimyristoyl-sn-glycero DMPC C36H72NO8P 14:0 677.933 297
-3-phosphocholine
1,2-dioleoyl-sn-glycero DOPC C44H84NO8P 18:1 786.113 253
-3-phosphocholine
1-palmitoyl-2-oleoyl-sn POPC C42H82NO8P 16:0-18:1 ∗ 760.076 271
-glycero-3-phosphocholine
1-palmitoyl-2-oleoyl-sn POPS C40H75NO10PNa 16:0-18:1 ∗ 783.988 287
-glycero-3-phospho-L-serine
Table 1.1: Commonly used phospholipids. Chain length given in (m:n) format, where
m is the number of carbon atoms in a single tail, and n the number of double
bonds present. Main phase transition temperature (gel to fluid) is cited for
a single component membrane at full hydration [57]. Bold entries were used
in experiments discussed in the thesis. Entries marked with ∗ possess two
differently structured tails.
Biophysical experiments rely on simplification to characterize and understand
complex systems from the ground up. In the case of the complex biological membrane,
the number of components is reduced until precise and reproducible systems can be
produced and studied. Model membranes consisting primarily of lipids and small
amounts of other relevant molecules can be artificially created in the lab with relative
ease and good reproducibility. Lipid molecules self-assemble into two dimensional
5
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gel phase fluid phase
Figure 1.2: The gel (left) and fluid (right) phases of a DPPC lipid bilayer created in
a molecular dynamics simulation. From Sane et al. 2009 [60]. Notice
the difference in thickness and of chain features between the gel and fluid
phases.
bilayers, representing the backbone of the complex cell-membrane. Lipid bilayers
are capable of hosting many other biologically relevant molecules as well. The lipid
membrane forms a periodic, quasi-crystal structure, which lends itself to scattering
experiments using small wavelength probes like X-rays or neutrons.
1.3 Phase behaviour of lipid membranes
For a single component membrane, such as DMPC, the bilayer exists primarially in
two different, structurally distinct phases: the gel (Lβ) phase and the fluid (Lα) phase
[58], although other phases (ripple phases) exist in certain conditions. By tuning the
temperature or humidity of the sample these phases can be accessed. The dynamics
of the lipid molecules are drastically different for different phases. For example, the
lateral diffusion constant of a lipid in a pure DMPC bilayer in the gel phase are up
to two orders of magnitude slower than the same lipid in fluid phase, when measured
by fluorescence recovery after photobleaching [59]. A lipid in the gel-phase is closely
packed together with its neighbours, and as a result, the acyl chain tails extend to the
all trans conformation.
The phase accessed depends on the strength of the interaction between the lipid
molecules. The two phases are significantly different in physical properties. Figure 1.2
shows a simulated DPPC lipid bilayer in the gel and fluid phase.
The Lβ or gel phase is characterized by fully extended acyl tails in the
trans-orientation. This results in rigidity and a long z-axis. This rigidity and
lengthening allows for a tight packing of the lipid head-groups and a low area per
molecule [61].
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Lipid
Cholesterol
Figure 1.3: A chemical structure of cholesterol and a cartoon simplification (left) and
the DMPC chemical structure and simplification (right). Cholesterol and
DMPC chemical structures from Avanti Polar Lipids [48].
In the Lα or fluid phase individual lipid molecules undergo more thermal motions
than in the gel phase. The lipid head-groups are more loosely packed, and thus have a
larger area per molecule. The packing of the tails is not as efficient, due to the presence
of gauche “kinks” in the C-C bonds [61].
DMPC and DMPS lipids
In the experiments presented in the following chapters, model lipid membranes have
been constructed using primarily the zwitterionic saturated 14 carbon chain lipid
DMPC and a small amount of DMPS, a lipid with negative charge on the head group
and identical carbon chains to DMPC.
DMPC is one of the most well understood of the phospholipids [30, 62, 63, 64, 65,
66, 67, 68, 69]. The structure and dynamics of DMPC membranes have been explored
in a variety of environments (temperature, relative humidity, pH, salt concentration
and pressure). DMPC undergoes its main phase transition (from gel to fluid phase) at
∼24 ◦C, allowing both gel and fluid measurements to be accessed with relative ease in
a laboratory setting. As the majority of physiological lipid membranes possess some
charge, DMPS was also essential to create accurate model membranes, and to facilitate
interaction with protein [70].
1.4 Non-lipid membrane constituents
1.4.1 Cholesterol
Cholesterol (shown in Figure 1.3) also falls into the classification of lipid, but will be
discussed separately here due to its unique role in biological membranes. Cholesterol
is an essential component in animal membranes, allowing for the fluidity and flexibility
of the membrane to be precisely controlled [71]. Cholesterol contains a hydroxyl group,
which exhibits polar (hydrophilic) properties. The hydroxyl group is connected to a
bulky and rigid steroid and hydrocarbon chain, which exhibit hydrophobicity. The
large “body” (green section in Figure 1.3) and small “head” (red section in Figure 1.3),
when in a lipid bilayer, hinder the motions of the lipid acyl-chains, allowing for tighter
7
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packing. Eukaryotic cells can regulate the cholesterol content of cell membranes to
produce a range of functionality in the cells.
Cholesterol may also be a key component in the formation and functionality of lipid
rafts, although the presence of lipid rafts remains controversial [72]. Lipid rafts are
non-equilibrium, dense regions which form in the bilayer. For a short time, lipid rafts
provide a rigid structure which is necessary to host signalling or receptor proteins. The
stability provided by the high cholesterol concentration in this micro-environment is
necessary for protein complexes to assemble and function, and provides protection from
unrelated enzymes.
1.4.2 Protein
Proteins are also present in biological membranes in high concentrations. Membrane
proteins play a variety of roles in transport: moving molecules and ions across the
membrane, capturing and releasing signal molecules and allowing a cell to interact
with neighbouring cells. A protein can be classified as a bio-polymer, due to the many
amino acids which are linked together to form the larger molecule. The structure of a
protein is closely linked with its functionality. The primary structure of the protein is
simply a chain of amino acids. The amino acids interact with each other with hydrogen
bonding to form the secondary structure, containing alpha-helicies, beta-sheets and
turns. The secondary structure then influences the tertiary structure or “folding” of the
protein. This folding is a result of a minimization of the exposure of the hydrophobic
amino acids to the surrounding water while simultaneously attempting to maximize
favourable amino acid interactions [2]. The folded state of the protein is directly related
to the protein’s function. A protein’s folded geometry is stabilized by relatively weak
electrostatic forces, hydrogen bonds and sulfur bridges, and is therefore very sensitive
to the solvent in which the protein exists. A change in temperature, pH or salt-content
could result in a loss of this tertiary structure, so-called denaturing [73].
The majority of proteins exist as globule proteins, freely floating in an organism.
However, proteins which exhibit a hydrophobicity profile similar to a lipid bilayer
may also come in contact with or intercalate into the bilayer in order to reduce free
energy, either temporarily (peripheral membrane proteins) or permanently (integral
membrane proteins). These membrane proteins are estimated to make up >25% of
proteins in a given cell or organism [74]. Membrane proteins play an important role
in the biological processes involving the lipid bilayer, such as signalling, membrane
fusion and active transport of nutrients and ions. Two classes of the integral membrane
protein exist, monotopic or transmembrane. The integral monotopic proteins do not
span the entire length of the bilayer, instead they may penetrate partially through
a hydrophobic component, lay on the surface of the bilayer with an α-helix, exhibit
an electrostatic interaction with the help of external ions, or a combination of these.
Integral transmembrane proteins may pass one or more times through the lipid bilayer
with α-helicies or β-barrels.
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Amyloid-β peptide
A protein with fewer than 50 amino acids is often referred to as a peptide. One peptide
of particular interest is the amyloid-β peptide. The understanding of amyloid-β (Aβ)
and its effect on the neurons of the human brain have been of interest since the initial
observations made by Alois Alzheimer in the early 1900s. Alzheimer first reported
the presence of protenious plaques in the post-mortem brains of patients experiencing
symptoms of dimentia towards the end of their lives in 1907 [14]. In the century
that followed, much effort has been put towards a better understanding of the link
between amyloid-β and symptoms of Alzheimer’s disease, yet as it stands, no consistent
explanation of the origin of the disease’s symptoms exists [75].
Amyloid-β is produced through the cleavage of the long (770 amino acid) integral
membrane protein Amyloid Precursor Protein (APP). APP is expressed in many
mammalian cells, but highly concentrated in the synapses of neuronal membranes. The
APP is cleaved in the bilayer by γ- and β-secretases, resulting in the 37-49 amino-acid
long amyloid-β peptide. The most common cleavage product is 40 to 42 amino acids in
length, referred to by the number of amino acids present (i.e. Aβ1−40 and Aβ1−42), and
consisting of hydrophobic and hydrophilic components. After cleavage, the resulting
monomeric Aβ peptides may exit the bilayer and proceed to form oligomeric “seeds”
which recruit more monomers and eventually lead to plaques. Focus has been put on
dissolving or reducing the number of plaques formed, however fewer plaques does not
lead to in a decrease of symptoms [76].
If the Aβ peptides do not leave the lipid bilayer after cleavage, the presence
of monomeric peptides may influence the structure and dynamics and thus the
functionality of the biological membrane [22, 23, 44, 45, 70, 77].
1.5 Literature review
It is well known that the structure of the model membrane and the time rate associated
with dynamics can change substantially from lipid to lipid, and is closely related to the
temperature and humidity of the surroundings. The addition of other components to
the bilayer, such as cholesterol or protein also affects the structure and the motion of
lipids in the bilayer [59].
One can experimentally access the gel and fluid phases of a lipid bilayer by controlling
temperature and hydration of the sample. Raising the heat of a membrane sample
causes more fluctuations in the tails, breaking up the closely packed orientation. A
similar effect can be achieved through hydration. A bilayer with low hydration does
not experience the same freedom of movement as a fully hydrated bilayer. Above
98% relative humidity, a substantial swelling of the d-spacing, the total bilayer repeat
distance, occurs [63, 64, 78]. The additional water molecules near the hydrophilic side of
the lipid bilayer allow for fluctuations not possible in the dehydrated analogue, and as a
result dynamics are changed [66]. Since a fully hydrated bilayer in the fluid phase is the
most biologically relevant phase, many experimentalists strive to recreate this condition
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in membrane biophysics experiments. The challenges and strategies to achieve this will
be discussed in detail in Chapter 5.
The characteristics of the lipid molecules also play a significant role in the
macroscopic properties of the bilayer. The gel to fluid phase transition temperature
increases as the number of carbon atoms in the acyl-chain increases. The degree of
unsaturation (number of C-C double bonds in the tails) will also have a significant effect
on the bilayer phase transition temperature, each additional double bond significantly
decreasing the transition temperature [79].
As was previously mentioned, the addition of other molecules into the bilayer may also
significantly alter the dynamics of the system. Cholesterol, for example, is a necessary
component of animal cells, and is used to regulate the rigidity of the bilayer. With
the addition of cholesterol, the phase behaviour becomes more complex, and the liquid
ordered (Lo) phase manifests above ∼25% cholesterol (in DPPC) [80]. Many of the
membranes in animal cells and organelles contain large ratios of cholesterol, up to 50%
for mammal plasma membranes [46]. The presence of cholesterol at low concentrations
in the gel-phase of a lipid bilayer generally causes a decrease in order, increasing the
lateral diffusion rate. In the fluid phase, however, the opposite is true. The addition of
a small amount of cholesterol results in a slowing of the lateral diffusion [59].
In general, the addition of even small amounts of other membrane components into
a bilayer can cause significant changes in both the long-range and internal dynamics
of bilayer lipids as observed by fluorescence techniques and NMR [59] and by neutron
scattering [81]. The dynamics over these time-scales often determines or strongly affects
the biological functions, such as diffusion through a membrane, or integral membrane
protein behaviour [82].
1.5.1 Structure of model membranes perturbed by amyloid peptides
The structural parameters which characterize model membranes have been studied
successfully through diffraction techniques, notably X-ray and neutron diffraction
(see Section 2.2 for a detailed discussion of the experimental approach to such
measurements). Fourier reconstruction of either the electron or neutron density profiles
allows one to determine the organization of molecules across the lipid bilayer with
Ångström resolution. Other details can also be determined by scanning in-plane (i.e.
lipid hydrocarbon chain nearest neighbour distances). For a lipid bilayer consisting of
saturated lipid molecules, a typical bilayer density profile is shown in Figure 1.4. The
addition of small amounts of other molecules would change the electron/neutron density
at a particular part of the bilayer, giving a hint to the location. Additional molecules
may also disrupt the bilayer organization or change the lamellar repeat spacing.
In 1996, Mason et al. used X-ray diffraction to determine the location of the peptide
fragment amyloid-β25−35 a fluid phase lipid bilayer [84]. For a peptide introduced to
a bilayer hydrated with distilled water, the peptide resided only on the hydrophilic
surface of the POPC bilayer, however introducing a NaCl buffer resulted in a portion
of the peptides intercalating into the bilayer centre. This was observed with large
amounts of peptide (>10 mol%).
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Figure 1.4: Reconstructed electron density profile of a DMPC lipid bilayer. The profile
phosphatidylcholine (PC) group, the carbonyl-glycerol (CG) group and the
methyl groups are shown with their respective contributions as dashed lines
(left) and summed to create the total reconstruction (right). From Kuc˘erka
et al., 2005 [83].
The next measurement on the sub-nanometre organization of the lipid bilayer was
published in 2002 by Dante et al. [22]. In this paper, the group used deuterium labelling
of the Leucine residue to determine the peptide location in the bilayer. Two types
of bilayers were prepared, the zwitterionic POPC, and an anionic bilayer containing
POPS, having negatively charged headgroups, which replaces the need to use the NaCl
buffer solution. The pure POPC bilayer hosted two populations of the peptide, but the
signal from the intercalated portion was very weak, corresponding to approximately
1/8 of the peptide residing in the bilayer, and 7/8 on the surface. A slightly anionic
bilayer showed about a 1:1 distribution of the peptide.
This experiment was replicated by the same group in 2003 [70], but with a different
preparation protocol. The peptide was externally applied to the system after the
bilayers had already formed. Both techniques resulted in identical peptide placement.
Again, the bilayer was constructed with some negatively charged lipids, resulting in an
anionic bilayer.
Further experiments involving the full-length amyloid-β1−42 peptide have also been
carried out by the group. Unilamellar vesicles have been prepared and observed
using small-angle neutron scattering [23], and by neutron reflectivity and atomic-force
microscopy [85]. This peptide causes a bilayer thinning of and a softening as probed
by the atomic force microscope.
Recently, Dies et al. have performed an X-ray experiment with an anionic bilayer and
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the addition of either amyloid-β25−35 or amyloid-β1−42 [86]. Both peptides reside in
two populations in the bilayer. The higher resolution inherent to X-ray measurements
allowed for more structural details, including the orientation of the peptide (not just
the location) to be determined. The amyloid-β25−35 is best modelled as slightly tilted
from its axis, whereas the amyloid-β1−42 resides with its C-terminus in the centre of
the bilayer.
Experimental evidence has also been presented with systems containing cholesterol.
Cholesterol is an essential component of eukaryotic cells [56] and is found in high
concentration in neuronal synapses [87]. Dante et al. have measured the amyloid-β25−35
peptide in bilayers containing cholesterol [77]. They have shown that by increasing the
amount of cholesterol in the bilayer, the percentage intercalated peptide decreases, with
no observable signal for a sample containing 20 mol% cholesterol.
1.5.2 Dynamics of model membranes
The dynamic behaviour of a membrane is closely linked to the specific function or
functions the membrane must perform. These dynamics occur over a wide range of time
and length scales, with the larger properties of the bilayer arising from the properties
of the molecular bilayer components.
The dynamics of model lipid membranes, made of many identical lipid molecules, can
be divided into contributions from the head groups, the tails and the whole lipid. In
experiments, these are observed as a superposition of motions, including trans-bilayer
flip-flop, lateral diffusion, bilayer undulation and bending, protrusions out of the bilayer,
rotation of whole molecules and molecular components, conformational changes and
vibrations. These dynamics occur on length scales from Ångströms (local dynamics
of single lipids) to tens of nanometres (bilayer undulation and bending), and from
femtoseconds (molecular vibrations) to hundreds of seconds (trans-bilayer flip-flop)
in time (see Figure 1.5). The long-range motion is interesting due to the impact it
is expected to have on biological and pharmaceutically relevant bilayer properties,
whereas the internal motions may be linked to transport across the membrane and
trans-membrane protein processes.
The slowest bilayer dynamics are observable using mechanical (high-speed atomic
force microscopy) or fluorescence based techniques [38, 39, 88, 89, 90, 91] (fluorescence
correlation spectroscopy or fluorescence recovery after photobleaching). These
techniques allow one to observe dynamic processes with relaxation times occurring
on the ms and µs time-scale.
To observe faster processes, it is necessary to use techniques such as nuclear magnetic
resonance (NMR), neutron scattering or molecular dynamics simulations. NMR can
be used to observe processes with relaxations occurring on the ps to ms time-scale
with pulse-field gradient and field cycling techniques [92, 93, 94, 95, 96, 97], whereas
neutron scattering allows observation of processes occurring on the ps to ns range
[34, 35, 98, 99]. Molecular dynamic simulations produce data which can be compared to
these experimental techniques, with all-atom molecular dynamic simulations modelling
processes from the fs to µs range [67, 100, 101]. Due to restrictions in computing
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Figure 1.5: Typical relaxation times of dynamic processes of bilayer lipids. Each
dynamic process is grouped according to the order of magnitude of the
relaxations in time. A rough approximation of techniques used to measure
(or simulate) each dynamic process is shown in the lower half of the diagram.
power, a trade-off is often made between the spatial dimensions of the system and the
time-scales which are simulated.
For quasi-elastic neutron experiments (described in detail in Section 2.3) , which
measure incoherent scattering primarily from hydrogen atoms in the lipids, the
observation made is restricted by the instrumental resolution and the dynamic range
of the instrument [29]. The interpretation of the data is model-dependent. A guide
to constructing the models based on the instrumental parameters and the assumed
type of motion is presented in Section 3.1.2. For lipid bilayer samples, models using
convolutions of Lorentzian curves are often used, as this type of interpretation can
be related back to physical parameters. Recent experimental results from single
component lipid bilayers observe two [32] or three [31] dynamic processes (depending on
instrumental resolution), with relaxation times separated by orders of magnitude. This
includes a Brownian-like diffusion of the lipid centre-of-mass (with relaxation time on
the nanosecond time-scale), and other contributions from the internal lipid dynamics,
manifesting as restricted dynamics on the picosecond scale.
This interpretation can also be replicated by using molecular dynamic simulations.
The observation of the lateral mean-square displacement allows one to characterize the
type of dynamics occurring over various time-scales. Flenner et al., have calculated
the MSD over their entire simulation range, from ∼10 fs to ∼100 ns [27], as shown
in Figure 1.6. In this plot, three distinct regions can be seen. On the femtosecond
time-scale, the coefficient β of the centre of mass motion can be fit with β=2, a Gaussian
distribution. This region corresponds to the unhindered, ballistic regime before the
lipid starts to experience collisions with surrounding lipids. In the picosecond regime,
the time-dependence of the stretching factor is fit at ∼0.68, defining a sub-diffusive
regime. Finally, for times larger than a nanosecond, β approaches 1. In this case, the
only contribution observed is from the long-range diffusion of the centre of mass. The
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Figure 1.6: The mean-squared displacement of various atoms in a DMPC in a molecular
dynamics simulation. The solid black symbols represent the centre of mass
mean-square displacement of the lipid bilayer. The exponential dependence
of the MSD with t defines the stretching of an exponential function of the
autocorrelation function. Figure from Flenner et al., 2009 [27].
sub-diffusive contributions approach the pure Brownian definition for long times. This
type of simulation also leads to diffusion constants which can be compared, with good
agreement, to experimental techniques [27, 28].
The first quasi-elastic neutron scattering experiment on lipid bilayers perturbed by
amyloid-β peptides was performed by Buchsteiner et al. in 2010 [44]. This experiment
was performed using an instrument with energy resolution (∆E) of 93 µeV, which allows
for dynamics happening on the picosecond time-range to be observed. In this paper,
Buchsteiner presents two sets of dynamics; a “slow” process, with a typical relaxation
time of ∼14 ps, and a “fast” process with a typical relaxation time of ∼4 ps. The slow
dynamics were influenced by the addition of amyloid-β25−35, with an acceleration of
diffusion constants for temperatures far from the main-phase transition Tc, however
near the phase transition a slowing is observed. The “fast” process did not show any
change with the peptide presence.
A follow-up to this experiment in 2012, again by Buchsteiner et al. compares the
amyloid-β25−35 to a larger amyloid-β22−40, which is assumed to be the residues of
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the full-length peptide which intercalates into the membrane (based on hydrophobicity
arguments). These experiments were performed at 47◦C, far above the main-phase
transition temperature of the lipids. A fitting model using two Lorentzians was again
used. A qualitative comparison between the two peptides shows both peptides seem to
accelerate the lipid diffusion in the “slow” process, while no effect on the “fast” process
is observed.
1.6 Thesis overview
This leaves open some of the scientific questions discussed in this thesis. First,
the relaxation times of the fast and slow contributions observed by these neutron
scattering measurements have been an order of magnitude faster than the nanosecond
whole molecule diffusion predicted by molecular dynamics simulations. By using
a combination of instruments with a range of instrumental resolutions, it may be
possible to observe and deconvolute relaxations from one another, and to determine
what effect an amyloid-β peptide fragment may have on these processes. Second, the
interaction between various peptide fragments and cholesterol-rich membranes has not
been systematically studied. By observing the location and changes in the bilayer
structure with various amounts of cholesterol, a better understanding of this particular
peptide, and the interaction of peptides and cholesterol-rich bilayers in general can be
achieved.
The thesis is organized as follows: In this chapter the model biological membrane
system is introduced and a review of existing literature involving this system is
presented. Chapter 2 contains the theoretical principles and descriptions of instruments
and techniques used to study the system. In Chapter 3 experiments on model
lipid membranes with fragments of the (amyloid-β22−40) are presented, particularly
structural and dynamical changes induced by the peptide in a two component lipid
membrane. In Chapter 4 structure and dynamic changes induced by the amyloid-β22−40
and the full-length amyloid-β1−42 in more complex model membranes containing
cholesterol are investigated. In Chapter 5 techniques to control humidity for neutron
scattering experiments are discussed, and the development of an improved variable
humidity and temperature neutron scattering sample environment is presented, as well
as experimental results from the commissioning of the chamber. Finally, in Chapter 6
the results of all studies are presented together and future experimental direction is
discussed.
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2.1 Scattering techniques
The lipid bilayer samples described in Chapter 1 have the periodicity and order which
allows for the study of their properties with X-ray or neutron scattering experiments.
Properties of matter have been probed with radiation since W. C. Röntgen first
discovered X-ray radiation in 1895, for this discovery, he was awarded the very first
Nobel Prize in Physics in 1901 [102]. Only a decade later, two more Nobel Prizes were
awarded to Max von Laue (1914 [103]) and the father and son William Henry Bragg
and William Lawrence Bragg (1915 [104]) for the discovery of diffraction of X-rays
by crystals, and for furthering the analysis of crystal structures by means of X-ray,
respectively. Neutrons were discovered a generation after X-ray radiation in 1932 by
James Chadwick [105], and in 1935 he was awarded the Nobel Prize in Physics for this
discovery [106]. Techniques and instrumentation for neutron scattering experiments
were developed in the 1950s and 1960s, for which the Nobel Prize in Physics was
awarded to Clifford Shull and Bertram Brockhouse many years later in 1994 [107].
These and other advancements in the fields of X-ray and neutron scattering have lead
to a variety of techniques to manipulate and observe the interactions of photons and
neutrons with various complex samples. Scattering of X-ray and neutron radiation
has provided insight into the structural parameters and the dynamic properties of a
diverse range of materials and systems including super-conductors and other magnetic
materials, metals, polymers and biological materials (including protein crystals and
lipid bilayers).
Both X-rays and neutrons can be used for scattering experiments, although the
properties of X-rays [108] and neutrons [109] have some substantial differences. Some
physical properties of X-rays, neutrons (and electrons, for comparison) are listed in
Table 2.1. Experiments with X-ray radiation are often the preferred technique due to
the ease of production (bench-top, in-house sources exist) and the high flux. Because the
X-ray photons interact with the electrons of a sample, there is a limit of the thickness of
samples and the complexity of the experimental sample environment [110]. Although
the production of neutrons is much more involved and the intensity is significantly
lower, a few of the properties of neutrons make neutron scattering an attractive choice.
First, neutrons can penetrate much deeper into a sample (deeper than electrons or
protons, which are hindered by the electrostatic repulsion), because neutrons have no
charge [105]. This results in high transmission, which has both scientific and technical
advantages. Thick samples can be used, as the neutrons penetrate deeply, and complex
sample environments can be constructed (typically from aluminum, due to its high
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transmission) allowing for experiments with sealed, “windowless”, containers which can
achieve high pressure, well defined atmosphere (inert gas, high humidity) and unique
magnetic conditions. Second, neutrons scatter coherently and incoherently, which
allows the observation of incoherent dynamics [109, 111]. Third, the neutron scattering
cross sections are not dependent on the sample’s atomic number, which allows for
contrast variation and substitution, especially with the biologically relevant hydrogen
isotopes 1H and 2H [112]. Finally, neutrons have magnetic properties which allow for
observation of magnetic phenomena not possible with X-rays. Often a combination
of X-ray and neutron experiments are performed to take advantage of both types of
probes.
Table 2.1: Properties of common scattering probes
X-ray neutron electron
mass - 1.68x10−27 kg 9.11x10−31 kg
charge - - -1 e
spin - s=h¯/2 s=±h¯/2
velocity c ≤10 000 m/s <c
momentum h¯/c mv mv
energy hcλ
1
2mv
2 1
2mv
2
magnetic moment - −9.65x10−27J/T 9.27x10−24J/T
typical energy range 100 eV to 100 keV 1 meV to 500 meV 20 eV to 50 keV
2.1.1 X-ray and neutron production
The production of X-rays can be done on the large scale with a synchrotron, and on the
small scale with a high-voltage anode in lab-based set-ups. In a synchrotron, a charged
particle (proton or electron) is accelerated to relativistic speeds then bent with powerful
magnets. During the bending, photons with high energies and broad spectra are
produced. These photons pass through focusing and monochromating optics, interact
with the sample and are counted by detectors around the sample. Alternatively, an
in-house set-up offers convenience but with significantly lower intensities. X-rays are
produced by accelerating electrons with an electric field to a high speed in vacuum,
towards a metal target (the anode). The voltage involved is typically 10s of kV, which
generates a continuous radiation through the Bremsstrahlung radiation process. High
intensity, narrow wavelength bandwidth Kα and Kβ peaks are produced, with the
wavelength depending on the type of metal used for the anode.
The production of neutrons is limited to large-scale facilities. Neutrons are produced
either by a reactor or at a spallation source. A reactor source produces a continuous
neutron flux through a fission reaction held at criticality with a water or heavy-water
moderator. In the fission process (see Figure 2.1), the decay of a heavy atom such
as uranium is induced by a collision with a neutron. The nucleus, now heavier
by one additional neutron, decays into smaller daughter nuclei and releases two to
18
2.1 Scattering techniques
Figure 2.1: A nuclear fission reaction. Figure from FRM-II [113]
three additional neutrons. On average, one neutron continues on to induce the next
fission reaction, while the remaining neutrons are extracted and used for experiments.
Around the reactor core, neutron guides provide a pathway for the neutrons to exit
the containment vessel and travel to the instruments. These guides may originate
from the pool moderator, or from cooled or heated “sources”, devices which shift the
neutron energy higher or lower through collisions with a heated or cooled medium.
Details are shown in Table 2.2. Examples of neutron reactor sources are the BER-II
reactor at the Helmholtz-Zentrum Berlin in Berlin, Germany, the reactor at the Institut
Laue-Langevin in Grenoble, France and the FRM-II reactor at the Maier-Leibnitz
Zentrum in Garching, Germany, among others. All of the neutron experiments
contained in this thesis have been performed at these reactor neutron sources. The
typical flux of a fission reactor source is on the order of 1015 neutrons·cm−2·s−1, and is
limited by the ability to remove heat from the reactor core. As such, it is unlikely that
a reactor source with a significantly larger flux could be constructed.
To achieve larger neutron flux, spallation neutron sources have been implemented
[114]. In a spallation source, protons are linearly accelerated to high velocities, and
collide with a target made of heavy metal. This collision releases neutrons from the
target’s nuclei. Since the protons arrive in pulsed bundles, the resulting neutrons are
also produced in pulses. Due to the lower heat produced by this technique, larger
neutron flux on the order of 1017 neutrons·cm−2·s−1 may be produced, although not
in a continuous manner. Spallation sources exist at the SNS (Oakridge, USA), ISIS
(Oxford, UK), PSI (Zurich, Switzerland), J-PARC (Tokai, Japan) and soon the ESS
(Lund, Sweden).
2.1.2 Scattering theory
A scattering experiment relies on precise knowledge of the geometry and energy of the
incident and scattered beam. Changes in the scattering angle or the energy of the
photon or neutron relate to physical properties of the sample. The most common way
to discuss a scattering experiment is in reciprocal space, defining a wavevector (k⃗) for
the incident and final radiation, as is shown in Figure 2.2. The magnitude of k⃗ can be
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Cold Thermal Hot
Moderator H2/D2 H2O/D2O Graphite
Temperature (K) 25 300 2000
E (meV) 1-5 5-100 100-500
λ (Å) 3-30 Å 1-4 Å 0.4-1 Å
v (m/s) 700 2000 10 000
Samples soft matter condensed matter condensed matter
biology magnetism atomic structure
magnetism crystal structure liquids
Table 2.2: Properties of cold, thermal and hot neutron sources.
 neutrons
sample
detector2
kf
ki
Figure 2.2: A typical scattering experiment.
directly converted back to real-space with
⏐⏐⏐⃗k⏐⏐⏐ = 2π/λ. One can describe the resulting
difference between the final and initial wavevector with the reciprocal scattering vector
Q⃗, constructed from a scattering triangle as is shown in Figure 2.3, with the scattering
angle between the ki and kf vectors called 2θ.
ki
kf
Q=kf - ki
2θ
Figure 2.3: The scattering triangle, with the scattering vector Q⃗ defined as the vector
subtraction of k⃗i from k⃗f .
Depending on the set-up of the instrument used for the scattering experiment,
information about elastic (no energy gain or loss during scattering) or inelastic (a
gain or loss of energy through scattering) collisions can be gathered. For both X-rays
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and for neutrons, the radiation may be treated as a particle or a wave, depending
on what experimental conditions are to be probed. In the case of elastic scattering,
the scattered particle’s energy remains unchanged during a scattering event, which
extends to an unchanged wavelength (λ) using the Planck-Einstein relation for photons
(Equation 2.1), and the de Broglie relation for neutrons (Equation 2.2). The elastic
scattering for a large number of collisions forms interference patterns, which reveal
details of the structure and order of the sample. This type of experiment is referred to
as a Diffraction experiment, and will be further discussed in Section 2.2.
Ewave = pc = h¯kc =
hc
λ
(2.1)
Eparticle =
p2
2m =
h¯2k2
2mλ2 (2.2)
In the inelastic case, the scattered particle will gain or lose energy by interacting with
a sample particle with kinetic energy of comparable magnitude. The change in energy
between the scatterer pre- and post-collision is then analysed to determine dynamics of
the sample. The principles of inelastic scattering techniques, in particular relating to
quasi-elastic neutron scattering, will be discussed in section 2.3. Elastic and inelastic
scattering can be used to study both the structural and dynamic properties of biological
samples, using advantages provided by both X-rays and neutrons as scattering probes.
With neutron probes, a further separation of dynamics is possible by tailoring the
experiment to observe either coherent or incoherent scattering. Coherent scattering
arises from the constructive interference between wavelengths, and thus requires an
ordered sample. Coherent dynamics describe structure or shape as well as the
excitations of a lattice (phonons or magnons). Incoherent scattering arises from the
interference of neutrons scattering from a single particle at different times. Dynamics
probed by incoherent scattering can include both diffusive dynamics, with an average
scattering centred around a zero energy transfer, and molecular vibrations which centre
around a non-zero energy transfer value.
2.2 Structural measurements
A scattering experiment in which only elastic collisions are considered gives information
of the equilibrium structure of the system. Particles scatter from crystal or semi-crystal
structures in the system, resulting in an interference pattern which can be described by
the Bragg relation (Equation 2.3, and Equation 2.4 in reciprocal space), and is shown
in Figure 2.4. Constructive interference occurs if twice the spacing (d) multiplied by
the sine of the angle (θ) is a integer multiple of the wavelength of the wave.
nλ = 2dsin(θ) (2.3)
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⏐⏐⏐Q⃗⏐⏐⏐ = 4πsin(θ)
nλ
(2.4)
d
dsin
λ
Figure 2.4: A pictorial description of the Bragg condition.
To measure a scattering event, one must consider the total scattering of the system,
and determine how this relates to the detectable scattering. The total scattering
from the system (σtotal) is defined over a solid angle Ω (Equation 2.5). Due to
instrumental constraints, and because most of the scattering occurs in the forward
direction, detectors are built to observe only a selected section of the solid angle. The
differential cross section is thus defined as a geometrical portion of the total scattering,
and can be defined by the incident and final wavevectors (k⃗i and k⃗f ), the scattering
length of the sample (b) and the structure factor of the sample (S(Q)), as shown in
Equation 2.6 and in Figure 2.5. This is a simplification of the double differential cross
section which will be discussed in more detail in Section 2.3.
σtotal =
∫ 4π
0
dσ
dΩdΩ (2.5)
dσ
dΩ =
kfb
2
ki
S(Q) (2.6)
The scattering length of elements differs for the X-ray and neutron case. The X-ray
scattering length scales linearly with the atomic number of the element, whereas for
neutrons the scattering length does not follow such behaviour. The neutron scattering
length does not depend on the size of the nucleus, and must be experimentally
determined for each atom. In fact, isotopes of the same atom can have drastically
different scattering lengths (cf. 1H and 2H). This difference is often exploited in neutron
scattering experiments, to determine the phase input to the Fourier transformation,
through contrast variation. The contrast variation approach will be discussed in
section 2.2.2. The scattering length of some elements commonly found in biological
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ki
d
SampleIncident 
beam
Figure 2.5: The scattering differential defined for a section of solid angle Ω.
samples are listed in Table 2.3. Below, the X-ray and neutron approaches to studying
structure are discussed.
Table 2.3: X-ray and neutron scattering length of biologically relevant elements [112]
.
Element Z bX−ray bneutron
(x10−13 cm) (x10−13 cm)
1H 1 3.8 -3.74
D (2H) 1 3.8 6.67
C 6 16.8 6.65
N 7 19.7 9.36
O 8 22.5 5.80
P 15 42.3 5.13
S 16 45.0 2.85
2.2.1 X-ray diffraction
Experiments contained in this thesis using the X-ray diffraction technique were
performed using the Biological Large Angle Diffraction Experiment (BLADE) a
Rigaku SmartLab X-ray diffraction system set-up at McMaster University in Hamilton,
Canada. BLADE uses a copper rotating anode to produce photons with a broad,
continuous energy spectrum, a result of Bremsstrahlung radiation. Sharp peaks are
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also present, defined by the energy difference between electron shells. In particular,
due to the copper anode, a narrow Kα peak with wavelength of 1.541 Å is produced.
BLADE is operated with a maximum voltage of 45 kV and a maximum current of
200 mA, producing 1010 photons mm−2 s−1.
The photons pass through collimators and slits which focus the beam. The X-ray
source and point detector are on moveable arms which move on the surface of the
Ewald sphere. This allows simple calculation of the scattering in reciprocal space, and
has the advantage of a stationary and horizontal sample. The detector will scan along
the horizontal and vertical directions, counting at each position, and observing the
constructive and destructive interference relating to in and out-of-plane structure. A
diagram of the set-up is found in Figure 2.6.
Figure 2.6: General overview of the BLADE X-ray diffractometer. The X-ray path,
optics, sample stage and hydration chamber inside the BLADE casing.
Figure reproduced from [115].
A typical scan with BLADE lasts approximately 18 hours, and produces a two
dimensional reciprocal space map covering -0.3 to 3.1 Å−1 in Q⃗parallel and from 0
to 1.2 Å−1 in Q⃗perpendicular. With this 2D map, a reconstruction of the features leading
to scattering (i.e. reflectivity) is possible from the perpendicular (out of plane) data
at Q⃗parallel=0 (see Figure 2.7). Often the goal of a X-ray diffraction experiment is
to reconstruct the structure of the bilayer. With oriented samples, it is possible to
determine both in- and out-of plane structural details.
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Reflectivity
In-plane peaks
(Out-of-plane)
Figure 2.7: A typical 2D reciprocal space map of a stacked lipid bilayer (DMPC/DMPS)
sample at 93% relative humidity and 32◦C. Inset image of bilayer with
corresponding reflectivity signal at Q⃗parallel=0, and in-plane signal at
Q⃗perpendicular=0. Details are reconstructed through a Fourier treatment
(to be discussed in the following section).
Diffraction analysis
The structural details of the out-of-plane scattering are obtained from Fourier analysis
of the peaks centred at Q⃗parallel=0. The spacing between these peaks directly provides
the bilayer repeat distance, the d-spacing, by d = 2π/(Qn−Qn−1), as demonstrated in
Figure 2.8.
First, the position of each peak in the spectrum is determined from the reflectivity
curve. Plotting either the sine of the angle (or simply the magnitude of Q in reciprocal
space) against the order of the reflection, n, one expects a linear relationship (sin(θ)/n =
λ/2d or Q/n = 2π/d). If satellite peaks are present, and result in a linear fit with a
different slope, this indicates the presence of multiple domains with different d-spacings
in the sample (e.g. a coexistence of multiple lipid phases).
If no secondary domains are observed (all peaks relate to a single d-spacing), the
out-of-plane bilayer structure can be reconstructed using a Fourier summation (in the
presence of multiple domains, Fourier reconstruction becomes non-trivial). The integral
area (I(n)) of the peak relating to each reflection is determined, and used to calculate
the form factor (F(n), Equation 2.7) of each reflection [116]. The form factor is related
to the square-root of the peak intensity along with various experimental corrections,
multiplied by the Fourier phase factor eiϕn (discussed below). For these reflectivity
experiments corrections for the absorption, and the Lorentz factor should be considered.
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Figure 2.8: A reflectivity curve extracted from Figure 2.7, taking the vertical peaks
centred at Q⃗parallel=0. The spacing between adjacent peaks defines the
d-spacing, displayed here for the first and second reflections. Smaller
satellite peaks are often observed in a multi-component membrane,
indicating sub-domains or defects.
Other factors such as the multiplicity factor and polarization are not considered, as
lamellar samples do not result in symmetry-equivalent peaks coinciding on the detector
(e.g. in rhombohedrial phases), and the X-ray tube produces unpolarized radiation.
The absorption correction is necessary as the X-ray beam passes through a different
amount of sample, depending on its angle of incidence. For most biological samples,
low atomic number elements present in the sample, and relatively thin samples, result
in negligible absorption, and A(n) is approximated at ∼1 . The Lorentz correction
accounts for geometrical factors related to reflecting planes within the sample, which
will change the detected intensity [117].
F (n) =
√
I(n)A(n)sin(θ) · eiϕn (2.7)
The calculated form factor of each peak (2.7) is then summed to determine the
electron density of a unit cell, calculated using Equation 2.8, with ρo the total electron
density of the unit cell (calculated by considering the components of the sample), k
a scaling factor (determined by assuming the electron density at certain points of the
unit cell - i.e., the water electron density between bilayers) and d the experimentally
determined d-spacing. The theoretical electron density is a summation over an infinite
amount of form factors, but for X-ray diffraction experiments this infinite sum is
truncated to the amount of observable Bragg reflections, typically less than 10 for
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a lipid bilayer sample.
ρ(z) = ρo + (
2
kd
)
nmax∑
n=1
F (n) (2.8)
The Fourier phase factors, eiϕn , are not determined directly by the measurement from
the X-ray detector. Only the projection of the complex wave-vector onto the detector
is detectable. This projection provides a measurement of the amplitude, neglecting
the imaginary part (phase) of the form factor. This loss of information is a common
occurrence in scattering, imaging and signal processing, and is referred to as the phase
problem. For determination of the electron density of a lamellar system, perpendicular
to the bilayer plane, we assume a centro-symmetric density (ρ(−z) = ρ(z)). This
assumption allows one to replace the complex eiϕn = cos(ϕn) + i · sin(ϕn) by v(n) ·
cos(ϕn), where v(n) = ±1, thus simplifying a potentially infinite phase coefficient to two
values. The scattering density is now displayed in its simplified form in Equation 2.9
[118].
ρ(z) = ρo + (
2
kd
)
nmax∑
n=1
v(n) |F (n)| cos
(2πnz
d
)
(2.9)
This simplification is still not enough to confidently assign phases to the Fourier
reconstruction, as the number of potential combinations is 2n (for a typical
measurement of n=8 reflections giving 256 potential phases). With X-ray reflectivity
measurements, a common strategy is to determine the sign of the form factor by
gradually varying the hydration of the bilayer through humidity [115]. Hydration water
enters the bilayer and causes dramatic changes in the unit cell resulting in increasing or
decreasing reflectivity intensities, and thus changing form factors. This will be discussed
further in Chapter 5 [119].
Once the d-spacing, whole unit cell electron density, form factors and crystallographic
phases corresponding to each peak are determined, the Fourier reconstruction may be
performed.
To compare samples, it is necessary to rescale the electron densities with the scaling
factor k. The resulting scaled electron densities can then be overlaid or subtracted, to
determine small structural changes present. This analysis is presented in Chapters 3
and 4.
In-plane analysis
Along with the reflectivity data used to generate the out-of-plane electron density,
in-plane peaks also exist in the two dimensional reciprocal space map (Figure 2.7). The
ordering of the bilayer is not as regular in-plane when compared to the out-of-plane
reflectivity measurement, and consequently, the primary peak is wider and higher orders
are not observable. The broad peak observed at ∼1.4 Å−1 is assigned to the mean
spacing between lipid tails (∼4.5 Å in real-space). Other more well defined peaks may
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Figure 2.9: a) Individual Fourier components corresponding to the first five reflections.
b) Unscaled summation of electron density components in a), lipid and
water molecules overlaid to give a general idea of bilayer structure. The
highest electron density is found at the head-group region of the lipids, due
to the high concentration of heavy elements (phosphorous, oxygen) in the
headgroups. The lowest electron density is found in the tail groups, where
only carbon and hydrogen are present.
also be present, especially when more stable ordered structures form. The size and
geometry of these ordered structures can then be determined through peak assignments.
It is often the case that one observes in-plane peaks which are not vertical, but
exhibit some smearing or bending. This is the result of anisotropy in the sample,
leading to a bending of the bilayer or the presence of multiple domains which do not
join together. By integrating these peaks radially, analysis of the bending of the bilayer
may be performed.
2.2.2 Neutron diffraction
Neutron diffraction experiments were carried out using V1 at BER-II reactor at
Helmholtz- Zentrum Berlin (HZB, Germany), using MIRA at the FRM-II reactor at
the Heinz Maier-Leibnitz Zentrum in Munich and at the D16 diffractometer at the
Institut Laue-Langevin in Grenoble, France. The three instruments are very similar
(see Table 2.4 for a comparison), although MIRA has additional features which allow for
a wider range of experiments. V1 is typically used to measure biological membranes in
diffraction set-up, whereas at MIRA, the polarization and triple-axis option (analyser)
allows for magnetic excitations and other magnetic phenomena to be captured and D16
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can be used in small angle geometry. In the scope of this thesis, V1, MIRA and D16
were all used in identical set-ups, with only small differences in the incident wavelength
and detector geometry.
Table 2.4: Comparison of V1, MIRA, D16 diffractometers (HZB Website, FRMII
Website, ILL Website)
Instrument V1 (HZB) MIRA (FRM-II) D16 (ILL)
Location Berlin Munich Grenoble
Reactor power (MW) 10 20 58
Flux at sample (no s−1 cm−2) 1·107 1·107 1 · 107
Wavelength used (Å) 4.567 4.7 4.7
Monochromator PG (002) PG (002) PG (002)
Detector type 3He 10B 3He
Detector size (cm2) 19x19 20x20 32x32
Detector pixel size (mm2) 1.5x1.5 1x2 1x1
Polarization No Yes No
Analyser No Yes No
Figure 2.10: Set-up of the MIRA diffractometer at the Heinz Maier-Leibnitz Zentrum
in position 2. The incident beam leaves the neutron guide (NL6a) after
passing through the monochromator (2), diffracts through the sample (3),
then is captured by the detector (4). The analyser is shown by the circular
shape before the detector, but was not used in this set-up. Figure from
FRMII Website.
The set-up of the MIRA diffractometer in position 2 (geometry for smaller incident
wavelength) is shown in Figure 2.10. In this set-up, the wavelength of the neutrons
leaving the monochromator is well defined (∼4.7 Å). The rotation of the sample
generates sample constructive interference from neutrons resulting in Bragg peaks on
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the detector, corresponding to Equation 2.3. The detector is also moveable, and can
be positioned to capture peaks at an angle up to 2θ=60◦. For the lipid bilayer samples
measured, each sample produced between 5 and 6 Bragg peaks. Higher orders were not
detectable due the intrinsic disorder of the membrane and the background noise.
The V1 diffractometer at HZB was also used. A photo of the V1 membrane
diffractometer in Figure 2.11 shows the instrument.
Detector
Sample
Collimator and 
slits
t t
Neutron path
Ne
utr
on
 gu
ide
Figure 2.11: An overhead view of the V1 membrane diffractometer. Photo courtesy of
Thomas Hauß, V1, HZB.
Neutron diffraction analysis is handled similarly to X-ray diffraction (discussed
previously in Section 2.2.1), with some advantages and other techniques due to the
neutron scattering lengths. As is shown in Table 2.3, the neutron scattering length
of atoms does not depend on the atomic number, but is a seemingly arbitrary value
which must be experimentally measured. It is worth noting the difference between the
isotopes of hydrogen, with b1H=-3.74· 10−13 and b2H=6.67· 10−13 cm.
One advantage of neutron diffraction is the contrast difference between 1H and 2H
(or D) can be used for tagging specific atoms. Tagging of atoms using a substitution
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of hydrogen isotopes is a useful way to determine position or structural details of a
molecule in the unit cell. The substitution of hydrogen with deuterium is possible
in polymers, lipids or even in proteins. Since the isotopes have almost the same
chemical behaviour, structural changes are minimal . This is in contrast to tagging with
fluorescent markers in optical measurements or heavy atom tagging for X-rays, which
may influence structure or dynamics of molecules of interest. In this thesis, substitution
of deuterated amino acids into the amyloid-β protein was used to determine the position
of the protein within the lipid bilayer discussed in Chapter 3.
The hydrogen and deuterium scattering length difference also allows one to resolve
the phase problem. Although the hydration swelling method is also used in neutron
scattering, a unique feature of neutron scattering length differences of hydrogen isotopes
allows one to solve the crystallographic phase problem by changing hydration water
deuterium content. By using different concentrations of deuterated water (D2O) in the
humidity sample environment, changes in the form factor relating to different H2O/D2O
ratios can be observed and used to determine Fourier coefficients. A minimum of three
H2O/D2O ratios are necessary to determine the phase of a centro-symmetric sample,
and to check if it passes through an extinction. The sample must contain a significant
amount of hydration water in its unit cell to take advantage of this technique, and the
number of water molecules per unit cell should remain constant. The number of water
molecules is held constant with a humidity controlled environment.
The form factor of each peak should be linear, when plotted against the H2O/D2O
ratio. With this in mind, one can assign the v(n) = ±1 values unambiguously.
In a similar way to the X-ray diffraction example, the samples are scaled such that the
neutron scattering length density either agrees with calculated values for certain regions
of the unit cell, or behaves consistently among samples. At this point, the difference
between samples with and without deuterated tagging may be plotted together and the
location of the tagged molecules determined.
2.3 Dynamic measurements
Scattering experiments can also be used to measure sample dynamics. Dynamic
properties of the sample are reflected as energy changes induced by inelastic collisions
of scattered particles. Such energy gains or losses can be measured using an instrument
that is sensitive to the incident and scattered energy of the neutrons. Instead of a single
differential scattering cross section, as in Figure 2.5, the energy is also considered. The
result is the double differential cross section, Equation 2.11.
σtotal =
∫ 4π
0
∫ ∞
E=−∞
dσ
dΩdΩdE (2.10)
d2σ
dΩdh¯ω =
kf
ki
⟨
b2
⟩
S(Q, h¯ω) (2.11)
This treatment allows measurement of the dynamic structure factor, S(Q, h¯ω). In
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this case, the measurement of energy allows us to detect the various contributions to
the scattering length. The total scattering length (b) is related to the total scattering
cross section by σtot = 4πb2. The total cross section σtot is defined as the sum of the
incoherent and coherent scattering cross sections, that is σtot = σcoh+σinc+σabsorption+
σmagnetic contributions+. . .
To understand these contributions, we think about the scattering process caused by
a neutron interacting with the atomic nuclei in the sample. The scattering from the
sample depends on the scattering length, which depends on two factors: 1) the type of
isotopes in the sample and 2) the orientation of the nuclear spin of each nucleus. This
implies that even for a sample consisting of a single type of isotope, there is potential
for different scattering lengths [111].
Coherent scattering occurs when every atom in the system possesses a scattering
length equal to the average scattering length ⟨b⟩, which defines the coherent cross
section σcoh = 4π ⟨b⟩2. The coherent scattering arises from the interference of waves
interacting with the many nuclei in the sample.
Incoherent scattering arises from the correlation of the same atom in time. The
waves interacting with individual atoms do not interfere with each other, as in the
coherent case. The incoherent scattering cross section is defined as the difference
between the total scattering cross section and the coherent scattering cross section,
shown in Equation 2.13.
σinc = σtot − σcoh (2.12)
σinc = 4π
[
b2 − ⟨b⟩2
]
(2.13)
In the elastic case, presented in Section 2.2, the detectors see the interference from
coherent scattering, and incoherent scattering results in an isotropic, angle independent
background.
The dynamic structure factor, S(Q⃗, h¯ω) relates back to an intermediate scattering
function I(Q⃗, t), and a real-space correlation function G(r⃗, t) through Fourier
transformations. These relationships are discussed in the following section.
2.3.1 The van Hove formalism
In 1954, Leon van Hove introduced a mathematical formalism which links various
experimentally accessible functions describing particle correlation and time evolution
together through Fourier transformations [120]. In this quantum-mechanical treatment
of scattering events, the scattering can be represented in terms of energy, scattering
vector Q⃗, or their reciprocals: time and position. Different techniques allow
measurements of these values, and transforming between them can ease the
interpretation of data. The various correlation functions are also separable in terms of
the coherent and incoherent scattering, which further eases interpretation.
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The measurable double differential scattering cross section can be written as:
d2σ
dΩdh¯ω =
kf
ki
1
2πh¯
∑
jj′
⟨
bjb
′
j
⟩ ∫ ∞
−∞
⟨
exp
{
−iQ⃗ · R⃗j(0)
}
exp
{
iQ⃗ · R⃗j′(t)
}⟩
e−iωtdt
(2.14)
with R⃗j(t) the position of a scatterer at time t, and bj the scattering length. The
measured double differential cross section can be split into a coherent and incoherent
part. In Equations 2.17 and 2.18, the dynamic structure factor S(Q, h¯ω) is written in
a way which allows treatment of the coherent and incoherent scattering separately. In
the coherent double differential, the summation is over different particles, all j and j’.
Correlations considered here are from different nuclei at different times, preserving
the phase relationship between incident and scattered neutrons and thus leads to
interference scattering. The incoherent case, however, is a summation over individual
particles, j, and compares the position of the same nuclei with time. This excludes
the phase relationship between incident and scattered neturons, and does not result in
interference scattering.
(
d2σ
dΩdh¯ω
)
coh
= σcoh4π
kf
ki
1
2πh¯
∑
jj′
∫ ∞
−∞
⟨
exp
{
−iQ⃗ · R⃗j(0)
}
exp
{
iQ⃗ · R⃗j′(t)
}⟩
e−iωtdt
(2.15)
(
d2σ
dΩdh¯ω
)
inc
= σinc4π
kf
ki
1
2πh¯
∑
j
∫ ∞
−∞
⟨
exp
{
−iQ⃗ · R⃗j(0)
}
exp
{
iQ⃗ · R⃗j(t)
}⟩
e−iωtdt
(2.16)
The coherent and incoherent dynamic structure factors are defined as follows:
Scoh(Q⃗, ω) =
σcoh
N
1
2πh¯
∑
jj′
∫ ∞
−∞
⟨
exp
{
−iQ⃗ · R⃗j(0)
}
exp
{
iQ⃗ · R⃗′j(t)
}⟩
e−iωtdt (2.17)
Sinc(Q⃗, ω) =
σinc
N
1
2πh¯
∑
j
∫ ∞
−∞
⟨
exp
{
−iQ⃗ · R⃗j(0)
}
exp
{
iQ⃗ · R⃗j(t)
}⟩
e−iωtdt (2.18)
In the van Hove formalism, the dynamic structure factor is simply a Fourier transform
from time to energy of the intermediate scattering function, shown below.
Icoh(Q⃗, t) =
σcoh
N
∑
jj′
⟨
exp
{
−iQ⃗ · R⃗j(0)
}
exp
{
iQ⃗ · R⃗′j(t)
}⟩
(2.19)
Iinc(Q⃗, t) =
σinc
N
∑
j
⟨
exp
{
−iQ⃗ · R⃗j(0)
}
exp
{
iQ⃗ · R⃗j(t)
}⟩
(2.20)
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The intermediate scattering function can also be transformed in space, resulting in
a pair correlation function from the coherent scattering, and a self correlation function
for the incoherent case.
Gpair(r⃗, t) =
1
(2π)3
∫ ∞
−∞
Icoh(Q⃗, t) · e−iQ⃗·RdQ⃗ (2.21)
Gself (r⃗, t) =
1
(2π)3
∫ ∞
−∞
Iinc(Q⃗, t) · e−iQ⃗·RdQ⃗ (2.22)
The Gpair gives the probability of finding any particle at position R⃗ at time t, with
the condition that a particle is at the origin at time t = 0 (the two particles can also
be the same particles). On the other hand, Gself gives the probability of finding the
same particle which was at the origin at time t = 0 at position R⃗ at time t. In this
interpretation Gpair includes Gself . This interpretation makes it clear that structure
and collective dynamics manifest as coherent scattering, and that diffusion and local
dynamics manifest as incoherent scattering.
2.3.2 Observation of coherent or incoherent scattering
The coherent or incoherent scattering can be suppressed by modifying the scattering
properties of the sample (through deuteration), the instrumental technique used or
the geometry of the sample. The dynamic structure factor will show a combination
of signals, which may include an elastic and quasi-elastic signal, both centred around
h¯ω = 0, as well as inelastic peaks centred at non-zero energy transfer. These can be
seen in Figure 2.12. Depending on the sample and the instrumental geometry it may
not be possible to observe all of these contributions to the dynamic structure factor
simultaneously. Finally, by measuring a sample which is disordered, such as a hydrated
powder or a solution coherent signals can be suppressed.
The different scattering behaviour of hydrogen (1H) and its isotope deuterium (2H)
with neutrons becomes especially useful when dynamics are of interest. The incoherent
and coherent scattering behaviour of neutrons is vastly different (see Table 2.5), allowing
experimental systems to be designed to highlight certain types of dynamics. If one
wishes to observe diffusion or other incoherent dynamics of a hydrogen rich system, it
is possible to deuterate all molecules which are not of interest, decreasing the coherent
signal by a factor of ∼ 40, and observing the quasi-elastic broadening. If coherent
dynamics are of interest, deuterating certain parts of the sample and observing the
inelastic peaks provides a signal which comes primarily from the deuterated molecules.
This approach is often used for lipid bilayer studies. Through deuteration of the
hydration water and the lipid tails, one can observe primarily head-group dynamics
or by deuterating tails and observing the coherent signals information about collective
motions such as bilayer undulation and bending may be observed [34, 35, 99, 121].
In the scope of this thesis, the incoherent dynamics of lipids in the bilayer were
of interest. For all dynamic measurements, the hydration water was fully deuterated,
suppressing the incoherent water signal. Finally the inelastic peaks were not of interest,
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Figure 2.12: A general dynamic structure factor for a particular Q-value. Elastic
contributions (no energy transfer) appear with a width defined by the
instrumental energy resolution. A quasi-elastic signal, centred around the
h¯ω = 0, arises from diffusive dynamical processes. Inelastic peaks arise
from either coherent dynamical processes (phonons or magnons) or from
lattice vibrations or excitations.
and the measurements made were all using instrumental geometry which captured
primarily the elastic and quasi-elastic contributions to the scattering, around the δE =
0 in energy transfer. Such dynamics are revealed by neutron scattering and are further
discussed below.
2.3.3 Quasi-elastic neutron scattering
The incoherent scattering arising from relaxing motions in the sample appears as a
broadening of the elastic line, centred around ∆E = 0 (as shown in Figure 2.12).
To observe the inelastic scattering, an instrument must be capable of measuring the
neutron energy before and after the scattering event. The energy of the incident
neutron and of the scattered neutron are then compared. Experimentally this type
of measurement is performed by using the spin-echo, backscattering or time-of-flight
techniques. Spin-echo takes advantage of the polarizability of neutrons to observe
changes in neutron spin before and after scattering events. This technique does
not result in a measurement of the dynamic structure factor, but rather directly
measures the intermediate scattering function. Spin-echo measurements access the
longest relaxation times, with typical relaxations measured on the order of tens to
hundreds of nanoseconds. Backscattering and time-of-flight measurements result in a
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Table 2.5: Neutron incoherent and coherent scattering cross sections for common
biological elements. [112]
.
Element Z σincoherent σcoherent
(x10−24 cm2) (x10−24 cm2)
1H 1 80.27 -3.74
D (2H) 1 2.05 6.67
C 6 0.001 5.559
N 7 0.5 11.01
O 8 0.0008 4.232
P 15 0.005 3.307
S 16 0.007 1.0186
measurement of the dynamic structure factor. Experiments in this thesis in Chapter 3
used the backscattering and time-of-flight techniques, and will be explained in more
detail in the following sections.
Both the backscattering and time-of-flight techniques measure the dynamic structure
factor. An important feature of these measurements is the energy resolution. The
energy resolution is related to the observable time-window through the Heisenberg
uncertainty principle (Equation 2.23). The finer the energy resolution of an experiment,
the broader the observable time-window. In general, the backscattering technique
results in a high energy resolution (∼µeV ), giving access to a broad experimental
time window (∼ns), and thus access to dynamical processes with relaxation times in
the nanosecond time-scale. Time-of-flight instruments have typical energy resolution
of 10 − 100 µeV , giving access to the dynamics with relaxation times between 1 and
100 ps. The set-up of backscattering and time-of-flight instruments can be tuned to
observe particular dynamics.
σEσt =
h¯
2 (2.23)
Backscattering
A quasi-elastic neutron scattering instrument using the backscattering technique is
generally tuned to produce an energy resolution in the µeV range, and thus allows for
the measurement of dynamic processes in the ns time-range.
The backscattering technique relies on the scattering from a “perfect” crystal. If
the crystal properties are well defined with a very low mosaicity, divergence of the
incident beam is sharpened considerably at the backscattering angle (θ = 90◦ or 2θ =
180◦) due to Bragg’s law (see Figure 2.13). In backscattering quasi-elastic neutron
scattering instruments, this property is often used twice, first on the monochromator,
and second on the analyser. Backscattering measurements in this thesis were performed
on the samples in Chapter 3 at the IN16 Backscattering spectrometer at the Institut
Laue-Langevin in Grenoble, France.
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Figure 2.13: Divergence of wavelength at 45◦ and 90◦. Backscattering condition from
a “perfect” (infinitely small mosaicity) crystal sharpens any wavelength
divergence.
The IN16 spectrometer was (IN16 has recently been upgraded to IN16b in 2014)
located on a neutron guide which was aligned to a cold source (see diagram:
Figure 2.14). A deflector redirects the primary wavelength of the neutron beam out
of the neutron guide, which is then focused, and modified with a filter and chopper to
remove neutrons with energies much larger or smaller than desired. A second deflector
sends the neutrons towards the monochromator, this rotates with a frequency that
defines the neutron pulses. Before the neutrons hit the monochromator they have
a spread of energy. The Si(111) monochromator backscatters the neutrons, defining
a very narrow energy spread. The neutrons then scatter off of the sample and are
sent towards an array of carefully aligned Si(111) crystals, which act as a second
backscattering crystal. The neutrons pass through the crystal once again, and are
detected. In this set-up, with a stationary monochromator, the instrument is acting
more like a (very expensive) diffractometer, observing only the elastic scattering.
By attaching the monochromator to a Doppler-drive, a spread of incoming energy
is achieved. Since the neutrons are moving at a velocity of ∼1000 m/s, and the
Doppler-drive’s maximum velocity is closer to ∼1 m/s, each packet of neutrons will see
a slightly different monochromator d-spacing, as the monochromator moves towards or
away from the incoming neutrons. Thus each packet has an energy, and the scattered
neutrons are binned according to their respective energy changes.
Changing the chopper speed can allow access to narrower or broader energy
resolutions, defined in Equation 2.24, with Eo=2.08 meV, the characteristic energy
of a Si(111) crystal. The incident energy is defined by the monochromator, when it
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Figure 2.14: The backscattering spectrometer IN16. Diagram from ILL.
is stationary, Ei = Ef , and when the monochromator is being driven by the Doppler
Ei = mn2 (vo+vmono)2, with vo the incoming neutron velocity, and vm the instantaneous
velocity of the monochromator while the neutrons backscatter.
∆E = Em − Eo = 2Eo vm
vo
+ Eo
(
vm
vo
)2
(2.24)
Time of flight
A time-of-flight spectrometer generally accesses a lower energy resolution than the
backscattering spectrometer, ranging from 10 to 100 µeV . This relates to a
time-window on the order of 10 to 100 ps. The velocity with which a neutron travels
is defined by its energy through Ek = 12mv2. A time-of-flight spectrometer determines
the neutron energy by calculation of the time the neutron travels a known distance.
Typical instrument designs rely on a series of choppers (rotating discs with alternating
absorbing and transmitting portions) to select a neutron bunch and define the incident
wavelength spread. The rotation ratios between choppers at different locations along
the neutron path define the wavelength and the pulse-width of the incoming packet.
A simplified calculation of the energy broadening from the sample to detector can
be made by calculating the first and last neutron of a bunch to arrive at the detector.
In this simplification, we make the assumption that the incident neutron beam was
monochromatic, with every neutron possessing the same energy. This monochromatic
neutron bunch scatters with our sample, and a short time later arrives at the detector,
a distance dSD away from the scattering site. The first neutron arrives after a time to,
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and the last neutron arrives after a time t. The difference between the two times is
defined as ∆t = t− to. The spread in energy can be defined by spread in flight-times,
as in Equation 2.26.
∆E = h¯∆ω = 12mn (∆v)
2 = 12mnd
2
SD
(
∆ 1
to
− 1
t
)2
(2.25)
∆E = 12mnd
2
SD
(
∆ ∆t
t2o +∆tto
)2
(2.26)
In Chapter 3, experiments were done with the time-of-flight spectrometer TOFTOF
at the FRMII reactor at Heinz Maier-Leibnitz Forschungszentrum in Munich, Germany.
This spectrometer uses a series of choppers to define the energy spread of the neutron
bunch, and thus the energy resolution of the measurement. A schematic of this
spectrometer is shown in Figure 2.15. TOFTOF is named due to the two time-of-flight
(TOF) measurements which are done on a neutron bunch. The first TOF is the
monochromation of the incident beam, which takes place before the sample, and the
second TOF which describes the time it takes the neutrons to travel from the sample
to the detector.
Neutron guide NL2au
Pulsing chopper-pair
Neutron guide
1st order removal chopper
2nd order removal chopper and 
frame overlap chopper
Monochromating chopper-pair
Figure 2.15: Schematic of the time-of-flight spectrometer TOFTOF at the Heinz
Maier-Leibnitz Forschungszentrum in Munich, Germany.
The rotation speed of the choppers allows one to select the incoming wavelength,
which defines the observable energy and Q-range (shown in Figure 2.16).
2.4 Sample Preparation
The samples used in all experiments were prepared by dissolving all materials into
a solvent and depositing this lipid/protein/solvent mixture onto substrates with an
artist’s airbrush. In all cases, the required amount of lipid, cholesterol, or peptide was
measured either directly by weight, or by dissolving a weighed amount into a solvent
at a known volume, then distributing out aliquots by volume.
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Figure 2.16: The range of available scattering parameters for TOFTOF.
For samples containing peptide, the first step was to dissolve the peptide into
trifluoroacetic acid (TFA), at a concentration of ∼4 mg/mL. TFA has been shown
to prevent pre-aggregation of monomers before interaction with the membrane [122].
The TFA was then evaporated with a stream of Argon for ∼10 min.
All components were dissolved into a 4:1 volume ratio of chloroform:methanol in a
concentration of 15 mg/mL, and combined to the required ratio for each sample. The
dissolved mixture was sealed then sonicated in a water bath sonicator for ∼2 min, then
vortexed to ensure good mixing. The mixture was then introduced to the reservoir of
a clean artist’s airbrush (between samples excess solvent was sprayed through to clean
any residual material). The mixture was then sprayed slowly onto sample substrates
(Si-111 wafers in most cases). After sample deposition was finished, the samples were
placed into a vacuum desiccator at room temperature for a minimum of 12 h to allow
all remaining solvent to evaporate.
Samples were optimized for each of the three types of experiments in this thesis
(Figure 2.17). A typical sample for use in a quasi-elastic neutron setup had ∼100 mg
of sample material, ∼10 mg for neutron diffraction and ∼1 mg for X-ray diffraction.
The size and the amount of sample material was chosen based on the dimensions of
the incoming beam, and the type of scattering which must be detected. The size of the
beam for neutron scattering is generally larger with considerably lower flux than found
in X-ray setups. For a quasi-elastic experiment, instead of looking for high-intensity
peaks formed by constructive interference, one observes the incoherent scattering off
of the main peak spread over various angles and time-channels. Thus it is necessary
to use more sample material for a QENS measurement as compared to a diffraction
measurement.
This method of sample preparation results in well-oriented lipid bilayer samples
(average mosaicity between 1◦ and 5◦) [77, 123, 124, 125]. Based on the mass of
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10 mm
10 mm
1 mg
55 mm
25 mm
10 mg55 mm
25 mm
50 mg
(front and 
back)
Sample for QENS Sample for 
neutron diffraction
Sample for x-ray 
diffraction
Lipid multilayer 
Si (111) 
substrate
Figure 2.17: Lipid bilayer multilayer samples on Si(111). Each sample was optimized
for the type of experiment (a double sided sample with a total of 100 mg
for QENS: left, a 10 mg sample for neutron diffraction: middle and a 1 mg
sample for X-ray diffraction: right), but prepared using the same process
(as described in text).
sample material, the area of the wafer covered by sample and the measured d-spacing,
an estimate can be made of the number of lipid bilayer stacks on the sample. For the
samples described in this thesis, ∼10 000-50 000 bilayers exist on each sample substrate,
providing sufficient repeated layers to obtain a scattering signal.
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3 Amyloid-β fragment 22-40 in lipid
membranes
A clear understanding of membrane dynamics and the changes which occur in the
presence of the neurotoxic amyloid-β peptide is necessary to better understand the
origin of the symptoms associated with Alzheimer’s disease. In particular, the
experiments which follow test the effect of the lipid sized 22-40 peptide fragment, with
similar size and hydrophobicity to the bilayer lipids which make up the majority of the
sample.
Fragments of the full-length amyloid-β peptide are known to exist in situ, and from
a practical point of view, using part of the peptide which is thought to intercalate into
the membrane without including the hydrogen rich 1-21 residues reduces significantly
the scattering signal coming from the peptide itself, allowing a cleaner measurement of
the lipid dynamics. A molecular diagram is shown in Figure 3.1.
Figure 3.1: The full length (1-42 amino acids) peptide, and the fragment (22-40
amino acids) used in the following experiments. Samples were made with
a DMPC/DMPS mixture and a 1.5 mol% of amyloid-β22−40. Peptide
structures were presented using the PyMol graphics program [126].
3.1 Experimental results
In this chapter, experiments on a multi-component lipid membrane are presented. The
effect of a small amount of amyloid-β peptide on a model lipid bilayer are tested through
a pair of complementary experiments.
• Structural changes in the lipid bilayer are observed via neutron diffraction
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Table 3.1: The composition of the samples used for the structural investigations using
neutron diffraction.
DMPC DMPS Aβ22−40 pro Aβ22−40 deu
(mol%) (mol%) (mol%) (mol%)
lipid sample 92 8 - -
Aβprotonated sample 90.6 7.9 1.5 -
Aβdeuterated sample 90.6 7.9 - 1.5
experiments, using a deuterium labelled peptide fragment to determine the
location and structural changes induced by the peptide’s presence (Section 3.1.1)
• Dynamical changes of bilayer lipids observed with quasi-elastic neutron scattering
experiments, determining diffusion coefficients for a variety of dynamical processes
in the lipid bilayer (Section 3.1.2)
Lipid bilayer samples were prepared using the method described in Section 2.4.
For each experiment in this section, the lipid ratio of 92:8 mol% DMPC:DMPS was
used. DMPC and DMPS are lipids consisting of saturated 14-carbon tails. The
difference between the two lipids is the head-group; the PC in DMPC is a neutrally
charged phosphatidyl-choline group, and the PS in DMPS is a negatively charged
phosphatidyl-serine. Lipid membranes in biological systems possess charged lipids,
and for interaction between peptides and lipids, it is necessary for the membrane lipids
to contain a slight charge. Additionally, for samples containing peptide, a ratio of
1.5 mol% of peptide to lipid was used.
3.1.1 Location of deuterium tagged amyloid-β in a lipid bilayer
The primarily hydrophobic amyloid-β25−35 fragment intercalates into the membrane.
Up until this point, no experimental evidence has been presented showing that the lipid
sized amyloid-β22−40 interacts with the membrane, but due to hydrophobic arguments
it has been hypothesized that this peptide will also intercalate [45]. To determine the
location of the amyloid-β22−40 peptide fragment in the lipid bilayer, and to observe any
structural changes the peptide’s presence may induce, an experiment involving neutron
diffraction was performed. This experiment was performed at the diffractometer MIRA
at the FRM-II reactor in Munich, Germany (described in Section 2.2.2).
The samples which were measured are listed in Table 3.1. There were three samples
prepared using the procedure described in Section 2.4, with 10 mg of sample deposited
onto a single-sided silicon wafer. One control sample exists, containing only lipids.
The other two samples contain amyloid-β22−40 at 1.5 mol%. The deuterated sample
and the protonated sample are identical, except for the labelling of two Valine amino
acids (number 39 and 40) with eight deuterium atoms in the place of hydrogen. This
creates a sixteen deuterium atom label on one end of the peptide fragment, shown in
Figure 3.2. The protonated and deuterated peptide fragments will result in identical
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bilayer structure, with a signal difference due to the tagged label, making localization
possible.
Figure 3.2: The amyloid-β22−40 peptide (left) and deuterated (right) version, with
deuterated amino acids labelled by dotted circles and highlighted.
The samples were mounted in a goniometer and sealed in a temperature regulated
humidity chamber, held at 40◦C, and humidity regulated with a saturated K2SO4 salt
solution (∼98% relative humidity), as described in Section 5.2.2. All samples were given
at least 8 hours to equilibrate before a scan was started. Each sample was scanned three
times, with different D2O : H2O ratios (8%, 20% and 50%). These variable D2O : H2O
ratio measurements will be used to solve the phase problem when doing the Fourier
reconstruction in the following section.
The procedure in Section 2.2 was followed, first by summing up multiple scans to
increase statistics, then by fitting each of the summed peaks for the three samples
in question (shown in Figure 3.3). An exemplary data set (lipid sample) is shown in
Figure 3.4. For each peak, a single Gaussian and a linear background was used for
fitting. Notice the number of counts for each additional Bragg order (n). By the sixth
order, the signal was too weak to be observed in all samples, even for long counting
times.
The position of all peaks was used to calculate the d-spacing of each bilayer. The
lipid sample had a d-spacing of ∼50.2 Å, the protonated peptide ∼52.1 Å and the
deuterated peptide sample ∼52.4 Å. An inconsistency in d-spacing between the three
D2O : H2O ratios was observed, which was unexpected. This ±1 Å inconsistency can
be explained by the sensitivity to humidity. In the 98% relative humidity region, small
variations result in drastic changes. The intensities for each peak of each sample were
then plotted against the D2O percentage, to determine the Fourier phase coefficients.
Only the 8% D2O will be analysed. At this ratio neutron scattering length density
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Figure 3.3: The first five Bragg reflections from the lipid (blue), Aβprotonated (green)
and Aβdeuterated (red) samples. To plot these together, it was necessary to
display the data logarithmically.
of water is zero, which provides the most sensitivity to observe the deuterated label.
The Fourier phase coefficients, as well as the intensities from the Gaussian fitting
were then used in Equation 2.8 to recreate the scattering length density.
The reconstructed neutron scattering length density plots were then scaled (a general
scaling was made with the total neutron scattering length density of the unit cell), and
plotted together to compare the reconstructed densities. In Figure 3.5, the pure lipid,
and sample with protonated amyloid-β have been plotted together. The lipid neutron
scattering length density appears as expected, very similar to a DMPC bilayer in the
fluid phase [83]. The addition of the peptide results in a smoothing-out of the lipid tails,
and a lowering of the head-group intensity. The difference between the two samples
containing amyloid-β results in a maximum centred at ∼5 Å in the deuterated sample.
There is also a small contribution in the head-group region of the bilayer, which could
be assigned to peptides residing on the surface of the membrane. The deuterated label
is located on the 39 and 40 Valine atoms. This section of the peptide has been suspected
to interact with the lipid tails, due to the average hydrophobicity of the amino-acids in
this section [45].
With evidence that the peptide interacts with the lipid bilayer, and changes the
bilayer structure, the next step was to check if the peptide would change the dynamics
of the lipids in the bilayer.
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Figure 3.4: The fitted Bragg peaks for the first six orders of the lipid sample. The sixth
order (bottom right) was not fittable, due to a weak peak signal. Typically
5 peaks are expected for bio-membranes observed with neutron scattering,
due to mosaicity of the sample and background noise.
−
Figure 3.5: The amyloid-β22−40 peptide (left) and deuterated (right) version, with
deuterated amino acids labelled by dotted circles.
3.1.2 Lipid dynamics perturbed by amyloid-β peptide fragment 22-40
Structural evidence showing that the amyloid-β22−40 fragment enters into the lipid
bilayer and changes the d-spacing spurred the next step in the investigations, to see
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the effect of the peptide on the dynamics of lipids in the bilayer.
To observe the dynamical changes, a series of quasi-elastic neutron scattering (QENS)
experiments were performed. Refer to Section 2.3 for a brief experimental introduction
to this technique.
The silicon substrate with multilayer lipid sample (described in Section 2.4) is
mounted into an aluminum cylindrical chamber [127]. The substrate sits in a Teflon
holder. On either side of the sample are troughs which were filled with a K2SO4:D2O
saturated salt solution, and a small tissue to increase surface area and speed up
equilibration. The chambers are sealed airtight with Teflon, and the sample is given
a minimum of 12 h to reach a saturation equilibrium. Before and after measurement,
the sealed container with sample was weighed, to ensure the seal was leak-proof and
no water has evaporated from the cylinder.
Because the lipid bilayers are oriented on the silicon substrate, it is possible to
orient the sample with respect to the incoming neutron beam, allowing for anisotropic
measurements of the in-plane and out-of-plane lipid dynamics.
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Figure 3.6: A comparison between the elastic energy resolution of the four energy
resolutions used in this work. The energy resolutions span from 1 µeV
(FWHM: IN16) to 100 µeV (FWHM: ToFToF). More information on the
instrumental characteristics can be found in Table 3.2
To access a broad dynamic range, multiple measurements of the same sample at
different energy resolution were taken. Three spectrometers (two time-of-flight and
one backscattering) were used, allowing observation of relaxations from the picosecond
to nanosecond range. The instrumental parameters of each measurement are listed in
Table 3.2.
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Spectrometer ∆E (µeV) λ(Å) Qrange (Å−1) twindow (ps)
IN16 (ILL) 1 6.3 0.6-1.9 400-1240
IN5 (ILL) 15 10 0.3-1.1 10-83
ToFToF (FRM-II) 25 8 0.5-1.3 4-50
ToFToF (FRM-II) 100 5 0.7-1.7 1-12.4
Table 3.2: Spectrometers used and their respective elastic energy resolution (∆E),
wavelength (λ), Q-range and resolution time (twindow). Conversion from
energy to time was calculated using tresolution=1.24 µeV·ns/∆EFWHM [128].
An estimate of the lower limit of the time window was given by the dynamic
range, determined from the spectrometer’s characteristics, the upper limit is
estimated from the instrumental resolution, characterized with a vanadium
standard.
The normalized elastic resolutions of the four instrumental setups which were used
are plotted in Figure 3.6.
Figure 3.7: An oriented sample allows for measurements of both the out-of-plane
(45◦) and in-plane (135◦) scattering geometries. Neutrons, represented by
the dashed arrow travel towards the sample and are scattered with the
momentum transfer Q⃗ (thick arrow), defined by the vector subtraction
k⃗f − k⃗i.
If the sample scatters completely elastically the signal which is observed is simply
a Dirac-delta peak convoluted with the Gaussian energy resolution, resulting in a
Gaussian shaped signal. On the other hand, if some quasi-elastic dynamical processes
occur in the sample, a broadening of the signal will be observed. If the sample undergoes
more than one dynamical process, multiple broadening forms may be present. For
this reason, the energy resolution must be selected so that the effect of a range of
dynamic processes may be observed. A process which is too slow will have a very narrow
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line-shape, and will be indistinguishable from the elastic peak, whereas a process which
is too fast with have a line-shape that is much broader, and will only give rise to a flat
background signal.
The data from each of the instruments is first reduced and treated in LAMP [129].
This includes normalization to monitor counts, shifting data to ensure agreement
between energy transfer channels and calculation of the channel and angle of each
detector pixel to energy transfer and scattering vector, q⃗. To improve statistics, energy
and scattering vector channels are rebinned. The steps of this process are presented in
a flow diagram in Figure 3.8.
Figure 3.8: The data reduction and treatment steps presented in a flow diagram. The
left column procedure is carried out in LAMP, while the right column is
performed in MATLAB.
At this point in the analysis, each measurement can be represented by a two
dimensional intensity map, represented by the measured structure factor Smeasured
(Q,h¯ω). Figure 3.9 shows the same sample (DMPC/DMPS lipid sample) using identical
conditions (135◦ and 30◦C) for the four instrumental resolutions. In this figure, the
typical quasi-elastic broadening of each sample is observed, corresponding to a lowering
of intensity around ∆E = 0 with increasing Q, with intensity being redistributed
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outwards, towards positive or negative energy transfer.
IN16: 1 µeV resolution
E (µeV)
IN5: 15 µeV resolution
E (meV)
ToFToF: 25 µeV resolution
E (meV)
ToFToF: 100 µeV resolution
E (meV)
Figure 3.9: The measured structure factor Smeasured(Q, h¯ω) for the four instrumental
resolutions used (from top to bottom: 1 µeV: IN16, 15 µeV: IN5,
25 µeV: ToFToF and 100 µeV: ToFToF.) Colour intensity presents data
logarithmically.
It was mentioned previously (Section 2.3.1) that the structure factor may be
represented as an intermediate scattering function, through a Fourier transformation
from the energy (frequency) domain to the time domain. This treatment is a good
starting point to get a physical sense of what range of dynamic processes can be
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observed, and a general feel for the way the different instrumental resolutions relate
to one another. This approach is further developed in Section 3.1.2 below. The
accessible time-window and Q-range of each measurement is listed in Table 3.2 and
shown graphically in Figure 3.10.
Q
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T-window (ps)
10 100 1000
IN16
1 µeV
ToFToF5
100 µeV
Time of flight Backscattering
Figure 3.10: Accessible time-window and Q-range of each instrument used. ToFToF
measurements are represented in green (100 µeV ) and pink (25 µeV ), IN5
in red (15 µeV ) and IN16 in blue (1 µeV ). The time-of-flight instruments
had access to a time-window spanning from ∼1-100 ps, whereas the
backscattering spectrometer allowed access a range of ∼0.4-1.2 ns
Due to differences in the geometry of each spectrometer, and the changes made to
the incoming neutron beam to prepare the beam-packet, the same Q-range was not
measured for every instrument. However, all instrumental resolutions measured have
data for the Q=1 Å−1, and thus the data from this Q-value could be Fourier transformed
and plotted together.
The data was Fourier transformed using the Fourier Transform package in DAVE
[130]. The data is further treated by dividing by the instrumental resolution function
of each instrument, as determined by a scan of a vanadium standard. The data points
approaching the longest times begin to fluctuate and the respective uncertainties of
these points becomes very large, an artefact of the Fourier transform. A threshold
value of uncertainty was selected as the cut-off for each instrumental resolution, points
with uncertainties larger than the threshold were not included in the graph. The data
was also scaled such that all points fall smoothly together. The lowest resolution (fastest
time-window) measurement was chosen as the most accurate, and the remaining data
sets were rescaled to agree with this data set. This is necessary to account for variations
in instrumental geometry. The multiplication scaling factors ranged from 0.75 to 1.25.
The combined intermediate scattering function of the four instrumental resolutions are
plotted in Figure 3.11.
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Figure 3.11: The combined intermediate scattering function of all four measurements
of the 135◦, 30◦C lipid sample. ToFToF measurements are represented in
green (100 µeV ) and pink (25 µeV ), IN5 in red (15 µeV ) and IN16 in blue
(1 µeV ).
Building a dynamic model
Up until this point, no assumptions have been made about the nature of the dynamics
which are being observed. To describe the data, it is necessary to select a reasonable
model at this stage.
There is no universally accepted model to describe the dynamic structure factor
representing the motions of bilayer lipids. Most fitting models are constructed from a
combination of the functions listed below.
1. Dirac-delta: arising from stationary particles (and particles which are so slow
that they appear stationary in the time-window of the spectrometer)
2. Constant background: arising from particles moving too fast to be observed at a
particular spectrometer time-window
3. Lorentzian: arising from particles moving in a diffusive manner
4. Gaussian: arising from particles moving in an unrestricted ballistic or flow-like
manner
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5. Kohlrausch-Williams-Watts (KWW a.k.a. stretched exponential): arising from
particles which exhibit a range of diffusive motions, rather than one distinct
relaxation
SLorz(Q, h¯ω) = A(Q) · δ(ω) + (1−A(Q)) 1
π
Γ/2
(Γ/2)2 + (h¯ω)2 + bg (3.1)
SGauss(Q, h¯ω) = A(Q) · δ(ω) + (1−A(Q)) 1
σ
√
2π
exp
[
−ω2
2σ2
]
+ bg (3.2)
SKWW (Q, h¯ω) = A(Q) · δ(ω) + (1−A(Q))FFTω↔t
(
exp
[
(−t
τ
)β
])
+ bg (3.3)
Where:
Γ: is the Lorentzian FWHM.
σ: is the Gaussian width (FWHMGauss = 2
√
2ln(2)σ)
τ : is the relaxation time (Γ = h¯/τ)
β: is the stretching coefficient
FFTω↔t: represents the fast Fourier transform from frequency to time
It is commonly accepted that lipids exhibit Brownian diffusion over length scales
larger than the lipid nearest neighbour distance, modelled by a combination of the
Dirac-delta, Lorentzian and background functions [34, 35, 99, 121]. The line-width
of the Lorentzian with respect to Q is then plotted. If the line-width shows a Q2
dependence, a Brownian diffusion can be modelled and a diffusion coefficient may be
extracted from the data. Recently, some publications have modelled dynamics Gaussian
fitting models to describe a collective flow-like motion of lipids over short [36] and long
length scales [43, 131], with a linear dependence of the line-width on Q, providing a
mean lipid velocity. There have also been publications which use the KWW function
to model lipid tail dynamics, using the stretching factor β to account for the range
of motions along the tails, although the physical interpretation of this model is not
straightforward [132].
The most recent approach to modelling lipid dynamics involves two or more
Lorentzian functions, relating to dynamic processes separated by at least one order of
magnitude [31, 32]. The slowest of the relaxations (ns time-scale) fits well to a Brownian
diffusion process, whereas the fast (ps time-scale) Lorentzian functions deviate from the
Brownian model. Deviations (offsets resulting in non-zero line-width at Q=0) can be
interpreted as restricted motions, such as the motion of the lipid tails (confined by the
tail itself), or head-groups (restricted by neighbouring lipids). Deviations at large Q
can be interpreted as a jump-like diffusion, with lipids making rapid jumps to vacant
neighbouring sites.
For the IN16 backscattering measurement (with energy resolution of 1 µeV), three
test fitting functions were constructed using an elastic contribution (Dirac-delta), a
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constant background, and one of either a Lorentzian (Eq. 3.1), Gaussian (Eq. 3.2) or
KWW/stretched exponential (Eq. 3.3). These fitting attempts are shown in Figure 3.12.
An indicator of the quality of the fit is the calculated χ2 value, a sum of the difference
between each point and the fit. In general, the Gaussian function resulted in the largest
χ2, and the Lorentzian and KWW fit profiles were close, with KWW always a touch
better. For the remainder of the analysis, a model consisting only of Lorentzians was
used, as the fits are comparable, the Lorentzian fit function contains one less fitting
parameter and the physical explanation of a Lorentzian fit is much more straightforward
than the KWW model.
Working first with the combined intermediate scattering function shown in
Figure 3.11, and assuming that the time-range used allows us to observe all dynamics
(no background necessary), a single process can be described by the Fourier transform
of Equation 3.1, which transforms to an exponential decay function in the time-domain:
shown in Equation 3.4.
Ii = [Ai(Q) + (1−Ai(Q))exp(−t/τi)] (3.4)
An attempt was made to fit the data first with a single exponential, then with two
and finally with three. The product of three exponentials was necessary to provide a
reasonable fit. A sample of these fits for the lipid sample at 30◦C and 135◦ is shown in
Figure 3.13.
It is clear from Figure 3.13 that three relaxation processes occurring with well
separated relaxation times can be observed in our data. The relaxation times of these
processes vary with temperature, and with the presence of amyloid-β peptide, but no
further analysis was done on the combined intermediate scattering function. Instead,
with the knowledge of the general relaxation times, more detailed Q-dependent analysis
could be performed on the dynamic structure factor. These relaxation times are ∼1 ns,
∼20 ps and ∼5 ps. By comparing these relaxations to literature values, these processes
were assigned to different aspects of lipid motions, in particular, whole lipid molecule
Brownian diffusion occurring in the nanosecond range, local lipid dynamics associated
with rotation, ∼17 ps [35], chain kink diffusion ∼20 ps [121] and the dynamics of
hydrogen atoms found in methylene and methyl groups of the lipid chains, ∼3-8 ps
[133].
Thus a general intermediate structure factor capturing all three relaxations can be
defined in Equation 3.5. With the indicies 1-3 defining the three relaxations from
slowest (τ1 ∼1 ns) to the fastest (τ3 ∼5 ps).
Itheo(Q⃗, t) = I1(Q⃗, t) · I2(Q⃗, t) · I3(Q⃗, t) (3.5)
with
Ii(Q⃗, t) = [Ai + (1−Ai)exp(−t/τi)]
This general intermediate structure factor can then be expressed as a dynamic
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Figure 3.12: Potential fitting functions for the lipid sample at 30◦C measurement by the
IN16 backscattering spectrometer. Top: fit using Lorentzian based model
in Equation 3.1. Middle: fit using Gaussian based model in Equation 3.2.
Bottom: fit using Kohlrausch-Williams-Watts or stretched exponential
based model in Equation 3.3.
structure factor S(Q,h¯ω) through a Fourier transformation. It is important to observe
that multiplication in the time-domain is converted to convolution in the energy domain
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Figure 3.13: The combined intermediate scattering function for the lipid sample at 30◦C
and 135◦. Top: an attempted fit with a single exponential, Equation 3.4.
Middle: an attempted fit with the product of two exponentials. Bottom:
an attempted fit with the product of three exponentials. For the two and
three exponential fits, the individual components are plotted, as well as the
product. These have been shifted vertically by the amplitude for clairity.
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[134], resulting in Equation 3.6.
Stheo(Q⃗, h¯ω) = S1(Q⃗, h¯ω)⊗ S2(Q⃗, h¯ω)⊗ S3(Q⃗, h¯ω) (3.6)
with
Si(Q⃗, h¯ω) = [Aiδ(h¯ω) + (1−Ai)Li(Γi, h¯ω)]
and
Li(Γi, h¯ω) =
1
π
Γi/2
(h¯ω)2 + (Γi/2)2
There are limitations of what can be observed by each particular spectrometer.
It should only be possible to observe a specific relaxation when a spectrometer’s
instrumental resolution is close to the broadening which should be observed. Too
fast of a process results in a dynamic structure factor with a very broad full-width
at half maximum getting lost in the background noise, whereas a process which is
too slow is narrow and cannot be separated from the instrumental resolution. The
theoretical range is defined as 110(∆τresolution) < τi < 10(∆τresolution) [29] with
τres = 1.24ns·µeV∆E for a Gaussian-shaped resolution [128], although due to experimental
uncertainties this range is sometimes smaller. By comparing the τresolution of the
four measurements to the τi found from the analysis of the combined intermediate
structure, simplifications of the theoretical dynamic structure factor can be made
for each instrument. When a Lorentzian peak is too narrow (relaxation is too slow
for this resolution), this contribution can be approximated as a Dirac-delta function.
Alternatively, if a Lorentzian is too broad (relaxation too fast for this resolution), the
contribution can be approximated as a broad and flat background.
When convolving two Lorentzians together, the result can be approximated as
a Lorentzian with the width of the broader [31]. This approximation results in
relatively simple scattering functions for each of the spectrometer’s parameters, listed
in Equation 3.7 and 3.8.
SIN16(Q⃗, h¯ω) = A1δ(h¯ω) + (1−A1)L1 + bg (3.7)
SIN5,T oF8,T oF5(Q⃗, h¯ω) = [A2δ(h¯ω) + (1−A2)L2]
⊗ [A3δ(h¯ω) + (1−A3)L3] (3.8)
Using the model
Having generated a model which defines the relaxations which can be seen by each
spectrometer, the fitting process can begin. The measured scattering function must be
convoluted with the instrumental resolution and is rescaled by an instrumental scaling
factor F, as is shown in Equation 3.9.
The backscattering instrument captures a single relaxation τ1, and thus is fit with
a single Lorentzian. The additional relaxations only contribute to a flat background,
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as the dynamics are too fast to be observed on this spectrometer. An example fit is
shown in Figure 3.14 a).
Smeasured(Q⃗, h¯ω) = F ·
[
Stheo(Q⃗, h¯ω)⊗ Sresol(Q⃗, h¯ω)
]
(3.9)
Where:
Smeasured: is the measured dynamic structure factor, shown in Figure 3.9.
F: is an instrumental scaling factor
Stheo: is the theoretical dynamic structure factor
Sresol: is the resolution function, defined by the instrumental resolution
The time-of-flight instruments each will experience contributions from the two fast
relaxations τ2 and τ3. The slowest τ1 contribution will appear as a Delta-contribution.
Example fits from each spectrometer are shown in Figure 3.14 b), c) and d).
This fitting was performed for every Q value, to determine the broadening behaviour
of each Lorentzian function. It was found that the IN16 backscattering scan, measuring
on the ns scale, resulted in a Brownian-like broadening with respect to Q (Γ = 2h¯DQ2).
The time-of-flight scans required an iterative fitting process. The fitting process started
with the 15 µeV energy resolution scan (IN5). The narrow peak values (relating to τ2)
were then given as the start parameters for the 25 µeV ToFToF scan. The resulting fit
for this value was then used as the start parameter for the ToFToF 100 µeV scan. The
opposite order was then done with broad peak (relating to τ3). This iterative fitting
allowed both peaks to be fit with confidence, with the resulting slopes for each fitting
function agreeing within error. The results of the fits are shown in Figure 3.15, and
presented in Table 3.3.
It is assumed here that the small amount of amyloid-β peptide fragment is not enough
to significantly change the nature of lipid motions, but only to modify the diffusion
coefficients corresponding to these dynamics. Thus, the same fitting procedure is used
for samples containing and without the peptides.
Since some of the diffusion coefficients were very close (often with overlapping error
bars) statistical analysis was performed to test whether the differences between the
samples with and without peptide were significant. This was performed as an unpaired
t-test (also known as Welch’s unequal variances t-test [135, 136]). The statistic, t
(Equation 3.10), and the degree of freedom d.f. (Equation 3.11) of the test were
determined for each diffusion coefficient and its respective uncertainty and evaluated
at the 95% confidence limit.
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Figure 3.14: Exemplary QENS spectra and fits. For comparison, the Q∼1 Å−1 data
from the four experimental resolutions are shown. a)IN16: ∆E=1µeV,
b)IN5: ∆E=15µeV, c)ToFToF 8Å: ∆E=25µeV and d)ToFToF 5 Å:
∆E=100µeV. Data are shown on a logarithmic intensity axis with
respective error values in green circles. This data set was fit using
Equation 3.9, with Equations 3 and 4 of the main text as the theoretical
scattering function. The data collected using IN16 were fit using
Equation 3.7 with a single Lorentzian peak (pink), whereas two Lorentzian
peaks (pink and red solid lines) as in Equation 3.8 were used to fit the
IN5 (b) and ToFToF (c, d) data. The theoretical scattering functions
were constructed by comparing the instrumental observation range to the
relaxation times found using Equation 3.5
t = |m1 −m2|√
sm1
2
n1
+ sm2
2
n2
(3.10)
d.f. =
(
sm1
2
n1
+ sm2
2
n2
)2
(
sm1
2
n1
)2
n1−1 +
(
sm2
2
n2
)2
n2−1
(3.11)
Where:
mi: are the fitted diffusion coefficients
smi : are the standard uncertainty values of the diffusion coefficients
ni: are the number of data points
In the gel-phase (15◦C), the peptide’s presence changes the in-plane diffusion60
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Figure 3.15: Quasi-elastic broadening of the L1 (top), L2 (middle) and L3 (bottom)
FWHM plotted against Q2, fit to a Brownian diffusion model (L1), a
simplified diffusion model L2 and L3. The left column presents the in-plane
dynamics, and the right column presents out-of-plane. Square blue data
points correspond to the lipid sample, round green to the sample containing
amyloid-β at 15◦C and 30◦C. For the middle and lower data sets only the
ToFToF 100 µeV data is shown, but due to the iterative fitting process
the other two time-of-flight measurements result in the same fit.
coefficient of the nanosecond (L1) and mid-range (L2) dynamics. The sample with
peptide has larger diffusion constants than the pure lipid samples. All of the
out-of-plane diffusion coefficients as well as the fastest (L3) process in-plane are not
significantly changed by the peptide’s presence.
However, near the phase-transition temperature (30◦C) the L1 and L2 diffusion
coefficients show significant slowing both in-plane and out-of-plane. This is also seen
61
3 Amyloid-β fragment 22-40 in lipid membranes
L1:45◦ L2:45◦ L3:45◦ L1:135◦ L2:135◦ L3:135◦
15◦C D(x10−12 m2/s) D(x10−12 m2/s) Drot(x1010/s) D(x10−12 m2/s)
lipid 9.6±1.4 90±30 930±640 10.2±1.2* 3.6±0.1* † 1140±220
amyloid-β 10.1±0.6 100±20 630±450 11.7±1.4* 4.1±0.2* † 1160±200
30◦C D (x10−12 m2/s) D (x10−12 m2/s)
lipid 19.8±1.5* 127±22* 920±590 20.8±1.6* 250±30* 1620±300*
amyloid-β 14.3±0.9* 106±20* 760±600 15.8±1.4* 115±17* 1140±200*
Table 3.3: Diffusion coefficients determined from L1, L2 and L3 Lorentzian width with
respect to Q2. The L2 and L3 coefficients were calculated as an average
of the fitting for the three experimental energy resolutions which allow
observation of these relaxations. The in-plane, 15◦C values (labelled with †)
are the rotational diffusion coefficient. An unpaired t-test (Welch’s unequal
variances t-test [135]) was performed to determine the statistical significance
between diffusion coefficients of samples in the same experimental conditions
(temperature and sample orientation). Differences between sample diffusion
coefficients with and without peptide which are significant above the 5%
confidence threshold are marked with (*).
for the fastest (L3) diffusion constant when observed in-plane.
3.2 Conclusions and discussion
The structural and dynamic changes induced by 1.5 mol% of the peptide amyloid-β22−40
in anionic lipid bilayers (composed of 92 mol% DMPC and 8 mol% DMPS) were
observed using neutron diffraction and quasi-elastic neutron scattering, respectively.
Through neutron diffraction with a deuterium labelled peptide, the location of the
peptide marker could be determined, and the position of the peptide in the lipid bilayer
could be inferred. The 39th and 40th residues of the peptide were labelled, leading to
a clear maximum around ∼5 Å, providing evidence for peptide intercalation. This
is in agreement with other neutron and X-ray diffraction experiments on the shorter
amyloid-β25−35 peptide [22, 84, 86].
It is also worth noting that the bilayer d-spacing significantly increases (a
2 Å increase) for samples containing this small amount of peptide. This is seen for
both the hydrogenated and the deuterium-tagged peptides in the bilayer. This is in
agreement also with the previous structural measurements on other peptide fragments.
The increased d-spacing may be the result of the peptide entering into the fluid-phase
bilayer, and suppressing the fluctuations of the chains, a condensing effect, as has
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Figure 3.16: Diffusion coefficient comparison of the three relaxation processes at 15◦C
(left) and 30◦C (right) as reported in Table 3.3, the L2 and L3 diffusion
coefficients were averaged from the three time-of-flight measurement
results. A cartoon describing potential dynamical processes associated
with each relaxation is shown for each relaxation: a) whole lipid Brownian
diffusion, b) chain kink and lipid tail dynamics, c) methyl and methylene
group dynamics. The pure lipid sample is represented by the blue bars,
whereas the sample containing amyloid-β is shown in green. The 15◦C
in-plane τ2 (marked with †) was fit with a rotational diffusion model, units
are 1010 s−1. Statistically significant differences (95% confidence level) are
marked with ∗
been reported for cholesterol [137, 138]. With a very small amount of peptide, local
hydrophobic chains fluidity may be restrained. This strong local effect could also spread
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to lipids not in direct contact with the peptide, but lipids attempting to mitigate
the hydrophobic mismatch the peptide causes hydrophobic mismatch in the bilayer
[139, 140].
With strong evidence that the 1.5 mol% of amyloid-β22−40 peptide intercalates into
the bilayer and results in increased d-spacing, dynamical studies were carried out to
determine what effect this peptide would have on the lipid dynamics in the bilayer.
A series of quasi-elastic neutron scattering experiments on aligned lipid bilayer
samples with and without a 1.5 mol% peptide amyloid-β22−40 were performed.
Measurements at four different instrumental resolutions allow for processes in a
time-window from ∼1 ps to ∼1 ns to be observed. The data for Q=1 Å−1 was
Fourier transformed from the measured dynamic structure factor into the intermediate
scattering function. A combined intermediate scattering function was produced by
plotting the four dynamic structure factors together. Three processes could be observed,
and can be attributed to whole lipid molecule Brownian diffusion, chain-kink diffusion
and rotation, and methylene and methyl bound hydrogen atom dynamics.
In the presence of the peptide, a decrease in lipid diffusion coefficient was observed
in all three relaxation processes at 30◦C in the plane of the lipid bilayer, with a
dramatic twofold decrease occurring in the τ2 process: relating to lipid chain motions.
In the gel-phase, a slight increase of the nanosecond and mid-picosecond lipid diffusion
coefficients were found in the peptide containing sample in-plane, with no significant
change out-of-plane.
At 30◦C, near the phase transition temperature, the addition of the amyloid-β
peptide fragment causes a drastic decrease in both the nanosecond and picosecond
lipid dynamics. The addition of the peptide introduces an obstacle into dynamic lipid
membrane, and thus the lipid diffusion coefficients are up to two times smaller in the
presence of the amyloid-β peptide. The in-plane diffusion coefficients at 30◦C are shown
in Figure 3.16. The out-of-plane orientation also exhibits this trend, but the effect is
not as dramatic and is not statistically significant for the fastest process. This result
echoes our group’s previous observations of the short Aβ25−35 peptide fragment’s effect
on lipid dynamics. Near the phase-transition temperature (∼30◦C) the value of the
diffusion coefficient decreases with the addition of Aβ25−35 [44].
On the other hand, at 15◦C, in the gel-phase of the DMPC/DMPS mixture, the
addition of the amyloid-β peptide fragment causes an increase in the lipid diffusion
as observed over mid-picosecond to nanosecond timescales in-plane. If we take the
evidence from Section 3.1.1 that the peptide intercalates into the membrane, the
addition of this small amount of peptide may perturb the rigid gel-structure of the
lipid tails and may overpower or alter the gel phase interaction between lipid molecules.
This is in agreement with the observation at 15◦C made previously for the hydrophobic
Aβ25−35 peptide fragment[44]. The out-of-plane are not significantly effected by the
peptide.
Additionally, in 2012, our group measured the effect of the presence of amyloid-β
peptide fragments (22-35) and (22-40) on local lipid dynamics at 47◦C (fluid phase)
using QENS [45]. The spectra over all Q-values were summed and the resulting
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Lorentzian half-width with and without peptide was compared. The presence of both
Aβ25−35 and Aβ22−40 peptide fragments resulted in an increase of the width of the
quasi-elastic contributions, hinting at an acceleration of the lateral diffusion of the
lipids. In comparison to the 30◦C measurement presented here, the peptide’s effect of
lowering lipid diffusion may occur only near the phase transition temperature, while
at a higher temperature (47◦C, as was measured previously) this effect is not large
enough to compete with the kinetic energy of the system and as a result the peptide
increases the lipid diffusion coefficient. Further measurements are necessary to compare
this effect for the longer Aβ22−40 at fluid phase temperatures.
In the present study, the decrease of lipid diffusion caused by the addition of Aβ22−40
at 30◦C (near the phase transition) is reminiscent of the influence of cholesterol and
sodium glycocholate, as has been measured by Busch and Unruh [81]. Aβ22−40 has both
hydrophobic and hydrophilic domains, similar to cholesterol and sodium glycocholate.
The presence of both hydrophilic and hydrophobic domains may influence the observed
effect of these molecules.
A very recent study by Sharma et al. [33] uses a very similar approach to test
the effect of the antimicrobial peptide melittin, a peptide of similar length and
hydrophobicity to the amyloid-β22−40 peptide studied in this thesis. DMPC bilayer
samples were prepared with and without a small molar amount (0.2 mol%) of melittin
peptide and dynamical measurements were made in the gel and fluid phase of the
bilayer. In the gel-phase, a small but considerable increase of nanosecond lipid diffusion
was observed, whereas above the main phase transition temperature of the bilayer
a considerable decrease in lipid lateral diffusion was observed with the presence of
the peptide. These results reflect very closely the experimental findings presented in
Section 3.1.2.
As of today, there is no consistent explanation of the cause of the symptoms of
Alzheimer’s disease. There has been much discussion in the literature about the role
that amyloid-β peptides play in AD, and whether the toxicity arises from amyloid
peptide plaques, monomeric peptides, some oligomeric intermediate structure or a
combination of all of these forms [20, 141, 142]. The perturbation in lipid dynamics
which are observed in the model membrane reflect the more complex behaviour of lipids
in neuronal membranes, and may be responsible for autocatalytic increases in peptide
cleavage by β- and γ- secretases [7, 8, 18], changes in fusion and vesicle formation
processes involved in the signalling cascade [11, 12, 13, 26] or complications in ATP
production for energy demanding synaptic processes [9, 10].
The clear trend of decreased lipid diffusion at 30◦C, and increased diffusion at 15◦C
with the addition of only 1.5 mol% Aβ22−40 presented in this chapter indicates that the
lipid molecules’ dynamic behaviour is dramatically affected by even a small amount of
peptide. If monomeric forms of the peptide can cause changes in the diffusive motions of
the lipids in neural cell membranes, as was presented in this paper for model membranes,
significant changes to the processes which are regulated by lipid-lipid, lipid-protein and
protein-protein interactions will be perturbed, leading to toxicity.
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3.3 Notes
• A manuscript containing this work was published in Soft Matter.
– Barrett, M., Trapp, M., Lohstroh, W., Seydel, T., Ollivier, J., Ballauff,
M., Dencher, N. and Hauß, T. “Alzheimer’s peptide amyloid-β, fragment
22-40, perturbs lipid dynamics." (2016) Soft Matter. 12, 1444-1451.
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cholesterol-rich membranes
The next step in exploring the effect of amyloid-β fragments on model lipid membranes
was to create more physiologically realistic membranes. Cholesterol is present in the
membranes of eukaryotic cells, often in high molar ratios. The presence of cholesterol
regulates membrane fluidity, and is often associated with the formation of protein
complexes in the membrane [71].
A connection between Alzheimer’s disease and cholesterol was first proposed by
Sparks et al. in 1990 [143], but there is no consensus in the literature about cholesterol’s
role in the symptoms of the disease [144, 145, 146]. Approximately 25 mol% of the
molecules making up synaptic membranes are cholesterol [87], which would make the
synapse sensitive to cholesterol changes.
Cholesterol distribution and concentration in cells changes with aging [147, 148, 149],
with high cholesterol levels often viewed as a risk-factor for Alzheimer’s disease [150,
151]. Cholesterol has been shown to promote the activity of β secretase, increasing the
production of amyloid-β from the amyloid precursor protein [152]. On the other hand,
the neuronal cells of Alzheimer’s disease patients have been observed to be depleted
in cholesterol [153], leading to the notion that a cholesterol decrease allowed for the
symptoms to manifest.
To gain a better understanding of how cholesterol effects the interaction of amyloid-β
with lipid bilayers, experiments have been performed with various peptide fragments
and model membranes containing cholesterol. Dante et al. have experimented with the
amyloid-β25−35 peptide in bilayers containing cholesterol [77]. They have shown that by
increasing the amount of cholesterol in the bilayer, the percentage intercalated peptide
decreases, with no observable signal for a sample containing 20 mol% cholesterol.
Recently, Dies et al. have shown that for a model membrane with saturated cholesterol
plaques, the addition of the amyloid-β25−35 peptide pushes cholesterol out of the lipid
portion of the bilayer and causes an increase in the amount of cholesterol in the plaques
[86].
The interaction of larger peptides with cholesterol-rich membranes has not been
characterized to high resolution of structural scattering experiments. In the following
chapter, the structural changes in anionic lipid bilayers containing cholesterol induced
by the full-length amyloid-β1−42 and the fragment amyloid-β22−40 are presented.
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10 Å
Figure 4.1: Schematic of the experimental setup. Samples were prepared with
DMPC and DMPS lipids, cholesterol and amyloid-β22−40 or amyloid-β1−42
peptides. The samples were prepared as multiple hydrated lipid bilayers on
a silicon substrate. The in- and out-of-plane X-ray scattering is gathered
in a 2 dimensional reciprocal space map with a point detector.
4.1 Experimental results
X-ray diffraction experiments were performed on a series of samples consisting of a
92 mol%DMPC: 8 mol%DMPS lipid ratio and a variable amount of cholesterol, ranging
from 10 mol% to 50 mol%. A selection of samples also contained 1.5 mol% of amyloid-β
peptide, either the fragment amyloid-β22−40, or the full-length amyloid-β1−42. The
composition of these samples, as well as experimentally derived quantitative parameters
are presented in Table 4.1. Lipid bilayer samples were prepared using the method
described in Section 2.4, depositing a mixture of lipids, cholesterol, peptide and solvent
using an air-brush onto silicon wafers and allowing the solvent to evaporate in a vacuum
desiccator after deposition. The samples were hydrated to 91% relative humidity
in a sealed aluminum container with thin Kapton windows, and held at a constant
temperature of 32◦C during the X-ray diffraction experiment.
The details of the X-ray diffraction experiment are described in Section 2.2.1. The
diffraction experiments resulted in a 2D reciprocal space map for each sample, providing
separate information on both the in-plane and out-of-plane structure of the model
membrane sample simultaneously.
The reciprocal space map obtained for each sample was treated in two separate fitting
procedures to determine in-plane and out-of-plane details of the samples. The first, and
most straightforward procedure was to determine the nearest-neighbour distance of the
lipid hydrocarbon tails, in-plane. An integration of the intensity in-plane is made (as
shown in Figure 4.3 a).
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Figure 4.2: 2D reciprocal space maps of a selection of samples at 93% relative humitidy
and 32◦C. a) DMPC/DMPS (92/8%) lipids, b) lipid with 1.5 mol%
amyloid-β22−40, c) lipids with 30 mol% cholesterol, d) lipids with 30 mol%
cholesterol and 1.5 mol% amyloid-β22−40, e) lipids with 40 mol% cholesterol
and f) lipids with 40 mol% cholesterol and 1.5 mol% amyloid-β (22-40).
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Figure 4.3: The in-plane nearest-neighbour fitting procedure. a) The reciprocal space
map of a DMPC/DMPS sample, the red box indicates the area to
be integrated, from 0 ≤ Q∥ ≤ 0.2 Å. b) The integrated intensity
curve displayed logarithmically. c) A Gaussian fit to the lipid tail
nearest-neighbour distance peak. The peak-centre qT is used to determine
the nearest-neighbour distance, and the area per lipid.
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This nearest-neighbour distance is then used to calculate the area per lipid (AL =
16π2/(
√
3qT 2) [115, 154, 155], with qT being the centre of the Gaussian peak used to
fit the area per lipid. The assumption was made that the lipid tails are structurally
ordered in hexagonal lattice, which is broad due to thermal fluctuations of the tails in
the fluid phase. On the other hand, in the gel-phase of pure DMPC, the tails are much
less mobile, resulting in sharper peaks (see reference [115]).
The out-of-plane scattering provides much more detailed information than the
in-plane, and as such, the analysis is much more involved. The first step is to determine
the lamellar repeat spacing (d-spacing) of the sample. Since the sample itself is made
of thousands of repeating lipid bilayer/water units, with regularly spaced regions of
different electron density the scattering arises as a series of constructive scattering
peaks or Bragg peaks. By fitting the location of each of these peaks in reciprocal space,
and converting to real-space (d = 2π/Q), the d-spacing of the sample can be determined
with great accuracy. This procedure is presented in Figure 4.4.
The next set of data which can be extracted from the out-of-plane scattering peaks is
the electron density of a unit cell in our sample. For each peak identified in the previous
step, the area under the peak was determined with a trapezoidal integration. The phase
coefficient array was taken as identical to the phasing used in [155], that is [-1 -1 1 -1
1 -1 1 -1 1 1 -1 ]). With these details, as well as the d-spacing (determined above),
the Fourier reconstruction for selected samples was performed resulting in an electron
density profile for each sample. This process is described in detail in Section 2.2.1.
From the electron density profiles, the maximum-to-maximum (dMM ) distance can
be estimated (from the peaks of the electron density profiles). In the cases of a bilayer
without peptide, this can be used to quantify the head-to-head distance, although
with peptide the electron density can be further affected. An estimate of the water
thickness (dwater) can also be obtained, by subtracting the total d-spacing from the
maximum-to-maximum distance. These parameters are presented in Table 4.1.
The data presented in Table 4.1 has also been plotted in Figure 4.6. By following
the changing parameters with increased cholesterol content, some trends begin to
emerge. The samples which do not contain any peptide behave very similar to
a DMPC/cholesterol system as described in reference [155]. For samples with a
cholesterol content greater than 40 mol%, additional peaks which can be associated
with cholesterol plaques, or a mixed lipid/cholesterol layer emerge. The d-spacing of
the bilayer increases slightly with increased cholesterol content in the lower cholesterol
range (<40 mol%), which is to be expected for a fluid-phase saturated lipid bilayer
system [156]. At 40 mol%, a drop in d-spacing is observed, which is linked to formation
of cholesterol plaques, therefore cholesterol leaving the lipid region of the bilayer. The
50 mol% cholesterol sample’s d-spacing is very similar to the 40 mol%, indicating that
the excess 10% cholesterol simply joins the plaque.
The presence of only 1.5 mol% of the peptide present in the sample results in an
increase of the solubility limit of cholesterol in the bilayer. In reflectivity curves for the
40 mol% sample without peptide (Figure 4.5 a), peaks associated with the cholesterol
plaques and a mixed domain containing cholesterol and lipid molecules are observed.
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Figure 4.4: The out-of-plane nearest-neighbour fitting procedure. a) The reciprocal
space map of a DMPC/DMPS sample, the red box indicates the area to
be integrated, from 0 ≤ Qz ≤ 1.2Å. b) The integrated intensity curve
displayed logarithmically. c) The reflectivity and lines fit to peak maxima,
used to determine the d-spacing of the sample.
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DMPC DMPS Chol Aβ22−40 Aβ1−42 d* dMM* dwater* AL
(mol%) (mol%) (mol%) (mol%) (mol%) (Å) (Å) (Å) (Å2)
Without peptide
92.0 8.0 0 - - 50.3 35.2 15.1 46.0 ± 0.2
82.8 7.2 10 - - 52.7 - - 46.4 ± 0.4
64.4 5.6 30 - - 54.3 39.7 14.6 46.7 ± 0.1
59.8 5.2 35 - - 54.3 - - 47.3 ± 0.2
55.2 4.8 40 - - 51.8 40.5 11.3 51.8 ± 0.4
46.0 4.0 50 - - 51.4 - - 53.6 ± 0.3
Aβ22−40
90.6 7.9 0 1.5 - 52.0 37.8 14.2 46.5 ± 0.1
63.4 5.5 29.6 1.5 - 53.2 40.0 13.2 50.2 ± 0.3
54.4 4.7 39.4 1.5 - 54.8 41.4 13.4 47.6 ± 0.1
45.3 3.9 49.3 1.5 - 58.4 - - 50.5 ± 0.3
Aβ1−42
63.4 5.5 29.6 - 1.5 55.3 39.1 16.2 46.7 ± 0.2
54.4 4.7 39.4 - 1.5 54.6 40.4 14.2 47.6 ± 0.1
45.3 3.9 49.3 - 1.5 52.7 - - 50.3 ± 0.3
Table 4.1: Composition of samples and measured sample parameters. d: lamellar
repeat distance calculated from the Bragg peaks found in the reflectivity (all
experimental uncertainties ±0.1Å), dMM : maximum-to-maximum distance
as determined from a Fourier reconstruction, dwat: water layer spacing;
calculated from d-dMM and AL: area per lipid, calculated from the in-plane
Bragg rod location. (* with an uncertainty of ±0.1Å)
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DMPC/DMPS lipids with 
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Figure 4.5: Reflectivity and peak assignment of a) DMPC/DMPS with 40 mol%
cholesterol, b) DMPC/DMPS with 40 mol% cholesterol and 1.5 mol%
Aβ22−40 and c) DMPC/DMPS with 40 mol% cholesterol and 1.5 mol%
Aβ1−42. Peaks which correspond to a lamellar phase are presented in red.
In the sample without peptide (a), peaks relating to a full cholesterol bilayer
(pink), and a mixed lipid and cholesterol bilayer (green) are also observed.
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These peaks do not appear in Figure 4.5 b, or Figure 4.5 c, the two samples with
peptide. The d-spacing at 40 mol% for both samples containing peptide does not drop
drastically in the lipid and cholesterol sample without peptide.
In Figure 4.6 a the sample series containing amyloid-β22−40 indicates that the bilayer
repeat distance continues to increase up to 50 mol% cholesterol (which was the highest
cholesterol sample produced). The d-spacing at 50 mol% cholesterol increases to a
dramatic 58.4 Å.
The sample series containing amyloid-β1−42, on the other hand, exhibits a gradual
decrease in d-spacing when the cholesterol content increases from 30 mol% to 50 mol%.
This decrease may be related to the fusiogenic effect of the full-length peptide [23]. This
decrease in d-spacing is linked to a decrease in water-thickness (dwat in Figure 4.6c).
The thinning of the water layer may be due to electrostatic effects of the hydrophillic
part of the peptide residing on the surface of the bilayer (as shown in the model fitting,
Figure 4.10 b and d)
4.1.1 Position of peptide fragments in a lipid membrane
The electron density was scaled using the electron density of the unit cell as determined
by the molar contents of each sample, and with the centre of the bilayer held at a
constant 0.22 e−/Å3, the density of a methyl (CH3) group found at the end of the
lipid chain. For samples containing amyloid-β peptides, the electron density profile was
further scaled to account for depletion of electron density caused by changing d-spacing
and lead to a clearer difference between samples with and without the peptide. This
step in the scaling procedure was also recently used by Alsop et al. to determine the
location of Ibuprofen molecules in DMPC [157].
Assuming no drastic changes in the bilayer structure with the addition of the peptide,
as was demonstrated in Section 3.1, the difference in electron density between the two
profiles can be made. The difference profile will describe the location of the peptide.
A difference plot for the DMPC/DMPS bilayer (without cholesterol) was created (see
Figure 4.7 a). The difference between the electron density profile without peptide was
subtracted from the counterpart containing 1.5 mol% amyloid-β22−40. This difference
is plotted in blue (measured) in Figure 4.7 b. A modelling procedure (described below)
is used to determine the position of the peptide.
It is worth noting that if the bilayer structure undergoes major changes in the
presence of the peptide, a direct subtration may not provide useful information
regarding the peptide location or orientation. A more direct method would be observing
deuterium labelled peptides in the bilayer. Since neutron diffration experiments are
limited by low neutron flux and thus a small number of Bragg orders, the resolution
of the Fourier transformation is often limited. The advantage to the X-ray diffraction
experiment is the high number of Bragg orders, resulting in detailed high-resolution
electron density plots, which can be compared with electron density profiles of peptide
molecules. In the cases presented by previous authors for the amyloid-β25−35 fragment
[22], and in this thesis in Figure 3.5 with neutron diffraction data, major changes in
the bilayer structure are not observed, and thus a comparison of the electron density
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Figure 4.6: The dependence of a) d-spacing, b) maximum-to-maximum distance, c)
water thickness and d) area/lipid on cholesterol content in the bilayer.
Three sets of samples are presented, the sample series without peptide
is represented by the blue circles and solid line, samples containing
amyloid-β22−40 are shown with green squares and dashed lines, and samples
with amyloid-β1−42 are shown with red triangles and dotted lines.
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Figure 4.7: a) DMPC/DMPS electron density profile (blue) and DMPC/DMPS with
1.5 mol% amyloid-β22−40 (black). The difference between the electron
density profiles is shown with a dotted line. b) The measured difference from
a) is plotted in blue overlaid with the calculated model peptide distribution
in green dotted. The two population model with one peptide population
on the surface and the other embedded in the membrane best fits the
experimental data.
profiles of a sample with and without peptide provides a high-resolution description of
the peptide location and orientation.
The peptide itself is a complex molecule, with a large atomic variation in structure,
and thus a complex electron density profile. To determine the position of the peptide,
models were constructed using a solution structure of the peptide from the Protein Data
Bank (reference 1IYT [158]). The orientation of the peptide was manipulated using
PyMol [126]. The resulting electron density in 3D is projected onto the axis to give the
electron density relating to the out-of-plane position. An example of one orientation of
this modelling is shown in Figure 4.8. The position of each atom is plotted along the
z-axis with the atom’s associated number of electrons (e.g. a Hydrogen atom will have
n−e =1, a Carbon atom has n−e =6). Since the peptide in our experiment was not in a
cryogenic state, a thermal fluctuation was introduced to the model. Each atom was
assumed to occupy a Gaussian distribution around the position derived from the PDB
coordinate. This results in an electron density profile model which can be compared
with the measured electron density profile.
4.1.2 Position of peptide fragments in a cholesterol rich membrane
Similarly to the pure lipid sample, the differences between samples containing
30 mol% and 40 mol% cholesterol were also measured (Figure 4.9). The electron
density differences in most cases (except the 40 mol% cholesterol with amyloid-β1−42
peptide) could not be modelled with a single peptide population, as was seen for
the cholesterol-free samples. The model which best represented the experimentally
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Figure 4.8: The modelled electron density profile of an amyloid-β22−40 peptide in the
“parallel” orientation (C-terminus parallel to the lipid bilayer hydrocarbon
tails). The blue fixed atoms data represent the number of electrons per
atom, according to the z-position of the atom. The highest blue peak at
∼6 Å relates to the Sulfur atom (16 electrons) found in the amino-acid
Methionine in position 35. The red-dashed line represents the electron
density with each atom represented by a Gaussian distribution arising from
thermal fluctuations.
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determined electron density profile for each sample and represented a physically
feasible situation was chosen. The modelled electron density profiles are presented
in Figure 4.10.
The position of each peptide was modelled above and below the solubility limit
of cholesterol in the bilayer, that is at 30 mol% and 40 mol%, for the fragment
amyloid-β22−40 and the full-length amyloid-β1−42.
Position of amyloid-β22−40
A two population model best describes the location of the 22-40 peptide, with one
population oriented parallel to the lipid tails, and the other rotated 90◦, laying on top
of the bilayer.
When increasing from 0 mol% cholesterol content and from 30mol% to 40mol%, no
change in the orientation of the surface population is observed, however the intercalated
population adopts a position where the long-axis of the peptide is parallel with the lipid
bilayer tails, slightly rotated from the 30 mol% case, and pushed further away from the
centre of the bilayer. The cholesterol-free sample’s electron density difference indicates
the end of the peptide resides near the centre of the bilayer, which agrees with the
labelled neutron experiments in Section 3.1, which showed evidence of the 39th and
40th residues intercalated into the bilayer.
This finding supports previous X-ray and neutron scattering results with the
amyloid-β25−35 peptide [77, 86]. Both of these publications report multiple peptide
populations in the lipid bilayer. In the X-ray experiment (Dies et al. [86]),
for a DMPC/DMPS membrane containing 30 mol% cholesterol, two surface bound
populations are modelled, plus an embedded (intercalated) state. In the neutron
scattering study (Dante et al. [77]), two peptide populations are observed, one on the
surface, and one embedded into the membrane. Dante et al. report in a POPC/POPS
membrane that as cholesterol content increases, the amount of peptide which embeds
into the membrane decreases, up to 20 mol% cholesterol, which completely prevents
intercalation.
Our modelling reflects this effect, as the ratio between surface and intercalated
peptides increases with increasing cholesterol content. At 30 mol% cholesterol a ratio of
55:45 surface:embedded was modelled, whereas at 40 mol% cholesterol the ratio changes
to 70:30 surface:embedded.
The two position model may also be related to the two stage model of
peptide/membrane interactions [159, 160, 161]. This model describes two positions
for a peptide. First: a peptide comes into contact with the membrane, typically the
membrane surface. Second: the peptide embeds itself into the membrane surface,
when the free-energy of insertion is overcome. The increase of cholesterol content may
increase the free-energy of insertion [162], resulting in a larger population of surface
and lower population of embedded peptides.
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(a) 30 mol% chol and 1.5 mol% Aβ22−40 (b) 30 mol% chol and 1.5 mol% Aβ1−42
(c) 40 mol% chol and 1.5 mol% Aβ22−40 (d) 40 mol% chol and 1.5 mol% Aβ1−42
Figure 4.9: Fourier reconstructions of out-of-plane bilayer structure. a) DMPC/DMPS
membrane with 30 mol% cholesterol (black line) and amyloid-β22−40 (green
line) and difference (black dotted line) b) DMPC/DMPS membrane with
30 mol% cholesterol (black line) and amyloid-β1−42 (red line) and difference
(black dotted line) c) DMPC/DMPS membrane with 40 mol% cholesterol
(black line) and amyloid-β22−40 (green line) and difference (black dotted
line) d) DMPC/DMPS membrane with 40 mol% cholesterol (black line)
and amyloid-β1−42 (red line) and difference (black dotted line)
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Figure 4.10: Measured electron density difference between sample with and without
peptide (blue solid line) and model calculation (green dashed line) for
a) 30 mol% cholesterol with Aβ22−40 peptide fragment, b) 30 mol%
cholesterol with Aβ1−42 full-length peptide, c) 40 mol% cholesterol with
Aβ22−40 peptide fragment, d) 40 mol% cholesterol with Aβ1−42 full-length
peptide. Models were calculated by determing the electron density profile
of solution protein structures from the protein data bank (reference 1IYT),
and determining a feasible orientation in the membrane which resembles
the measured electron density.
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Position of full-length peptide amyloid-β1−42
The position of the full-length peptide was modelled with the peptide C-terminus end
(residues >30) residing in the bilayer parallel to the lipid chains, and the N-terminus
laying on the bilayer surface. For the 30 mol% cholesterol sample, two populations were
necessary to model the double peak near the water layer. The 40 mol% sample can
be modelled with a single peptide population in the unit cell, with the peptide slightly
shifted in the bilayer, not embedded as deeply as in the 30 mol% case. This reflects
the increased cholesterol content expelling the peptide from the bilayer centre as was
discussed in Section 4.1.2.
Also noteworthy is the thinning of the water layer seen for samples with this peptide.
Figure 4.6 c) shows a drop in the water layer thickness of the full-length peptide samples
between 30 mol% and 40 mol% cholesterol, which is not present for the other samples.
It has been shown by using small angle scattering that the full-length peptide may have
a fusiogenic effect on the bilayer [23]. It has also been shown that the full-length peptide
produces pore-formation [85]. The segment of the peptide which lays on the membrane
surface may act via electrostatics to decrease the water layer between membranes and
to bring adjacent bilayers close together, as the first step to bilayer fusion or pore
formation.
4.2 Conclusions and discussion
Structural disruption, formation of pores and membrane fusion may all be changes in
the bilayer which occur and go hand-in-hand to give rise to the neurotoxicity associated
with Alzheimer’s disease.
The experimental evidence presented in this section, indicating both interaction
and intercalation of amyloid-β22−40 and amyloid-β1−42 peptides into anionic lipid
membranes containing cholesterol, supports the hypothesis that the monomeric forms
of the peptide may play a role in the origin of symptoms in Alzheimer’s disease.
Both peptides embed into a lipid bilayer containing 30 mol% and 40 mol% cholesterol,
however the higher cholesterol content prevents deep embedding into the core of the
membrane. The full length (1-42) peptide embeds into the bilayer, whereas the fragment
(22-40) exhibits two populations, one surface and one embedded. This observation may
be related to the two step model of protein insertion into the bilayer, with proteins first
coming into contact with the surface, and intercalating if the potential energy barrier
is overcome.
Evidence has been provided that both of these peptides increase the solubility limit
of cholesterol in the bilayer, preventing the formation of cholesterol plaques. High
concentrations of cholesterol are thought to be related to lipid rafts: highly transient,
dense lipid patches in the bilayer, which host protein complexes. Lipid rafts may be
involved with transport and signalling processes across the membrane, although this
hypothesis remains controversial [139, 163, 164, 165, 166]. If the peptide prevents the
aggregation of cholesterol, then the protein complexes which require stability to form
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may be hindered [13, 24, 167].
It has also been shown that the bilayer d-spacing is significantly changed with the
presence of peptides, especially at very high cholesterol content. Changes in bilayer
structure can be detrimental to sensitive processes such as the processing of amyloid
precursor protein (APP) by β- and γ- secretases. In the case that the bilayer is
thicker than expected, the secretases may not properly cleave the peptide, resulting
in neurotoxic fragments [18, 168, 169].
To compliment the structural measurements presented here, dynamic measurements
(with quasi-elastic neutron scattering, for example) would provide further insight into
this model system, and the complexities of lipid-peptide interactions in the membrane.
4.3 Notes
• A manuscript containing this work was published in the journal Membranes.
– Barrett, M., Alsop, R, Hauß, T. and Rheinstädter, M. C., “The position
of Aβ22−40 and Aβ1−42 in anionic lipid membranes containing cholesterol."
(2015) Membranes. 5(4):824-43.
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5 Humidity chamber as sample
environment
As mentioned previously in Section 1.3, the phase behaviour of a lipid bilayer sample can
be modified by changing the environment in which it resides. A model lipid membrane
is particularly sensitive to humidity and temperature. For biophysics experiments
using neutron scattering, fine control of these parameters has been largely hindered
by the performance of existing humidity sample environments. In order to advance
the experimental potential of neutron experiments, the scientific community decided it
was time to develop a new humidity sample environment which would allow for better
precision and stability and make experiments more flexible and more efficient.
A cooperation between the Helmholtz-Zentrum Berlin (Berlin, Germany) and the
Institut Laue-Langevin (Grenoble, France) was formed in the framework of the
NMI-3 JRA-20 project to design and build an improved humidity sample environment
for neutron scattering experiments. This project was carried out with three main
milestones, which will be discussed in the following sections.
• Overview of existing humidity sample environments and specifications of a new
humidity chamber: Section 5.2
• New chamber design: Section 5.3
• Building and commissioning of the new humidity chamber: Section 5.4
5.1 Humidity’s role in biological experiments
When planning an experiment involving biological membranes, one important
consideration is to measure the sample in a physiologically relevant environment.
To produce a sample environment that best replicates in situ conditions, one must
consider humidity and temperature. The lipid bilayer is very sensitive to both of
these parameters and therefore accurate and precise control of both humidity and
temperature is crucial.
The phase behaviour of even the most simple single component lipid bilayer is very
rich. For a lipid bilayer containing only DMPC, two main lipid phases exist. The gel or
Lβ phase is characterized by a more rigid bilayer with individual lipids having straight
tails (all trans-configuration) and well defined distances between lipids which allows
for close packing of the lipids. At higher temperatures or higher humidity the bilayer
transitions to the fluid or Lα phase characterized by more fluctuations in the lipid tails,
a looser lipid packing behaviour, faster lipid diffusion and a more flexible bilayer.
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Figure 5.1: Temperature and humidity phase diagram of a DMPC lipid bilayer. From
Smith et al. [58]
In the single component DMPC bilayer, other gel-like phases also exist, but can be
accessed only at high humidity (as seen in Figure 5.1). Smith describes two additional
Lβ phases which first appear at humidity greater than 80% relative humidity and are
characterized by tilted lipid orientations as a result of larger hydration forces. Finally,
at humidity levels ≥92 % r.H. in DMPC, a ripple-phase, or P ′β is achieved. The ripple
phase exhibits a very interesting diffractogram, with peak splitting as a result of ripples
in the membrane [170].
Of course, real biological membranes are much more complex than the single
component DMPC membrane, and also exhibit unique phase behaviour based on the
ratio of bilayer components present. Controlled dehydration has also been used to
induce fusion stalks between membranes [171] and to observe the protective effect of
sugars against membrane rupture while freezing [172].
Since most biological processes occur under fully saturated hydration conditions,
an obvious goal for experimental sample environments is 100% relative humidity.
With a fully saturated sample, the model bilayer would behave, both structurally and
dynamically, in a manner which is comparable to a natural membrane in excess water.
A lipid bilayer stack will slowly take up water with small increases in d-spacing until a
very high hydration pressure, where drastic swelling occurs [63, 173] (Figure 5.2). By
nearing this thick, fully hydrated state, the lipid behaviour in the bilayer begins to more
accurately represent the physiological case. However, this goal of full sample saturation
is accompanied by many complications which often prevents a sample environment from
reaching 100% relative humidity, including problems measuring the highest humidity
with accurate sensors, and cold points in the humidity set-up.
Therefore, humidity sample environments should have the ability to access both the
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DOPC
Figure 5.2: Swelling of a DMPC lipid multi-bilayer (left) and DOPC lipid multi-bilayer
(right) induced by relative humidity. From Kuc˘erka et al. and Ma et al.,
[83, 173]
rich phase behaviour of the middle humidity range, and to replicate the biologically
relevant high humidity region, all while controlling the temperature of the sample. In
this chapter, the development, design and commissioning of a new humidity chamber
for neutron scattering will be described.
5.2 Humidity control techniques and existing technology
To begin the design process, a survey of existing humidity control techniques was
conducted. The existing humidity set-ups were compared, and a plan to develop a
new chamber was made. In the following sections, each humidity control technique is
discussed and compared to the end goal of accurate humidity control over a wide range
of humidity while maintaining high temperature stability.
5.2.1 Bulk water
The most straightforward technique to reach a saturated (fully hydrated) lipid bilayer
sample is through the use of bulk water. The sample is directly exposed to excess water,
resulting in fast bilayer swelling [174, 175, 176, 177]. Although this technique is simple
and works exceedingly well to achieve saturation, it is also has some large limitations.
For example, an excess water environment may result in a loss of sample material.
This is especially true for charged lipids, which are susceptible to dissolving in water.
A charged lipid bilayer will disassociate from the substrate on which it was deposited,
losing the very order and structure which is of interest in a scattering experiment.
This is a problem due to the prevalence of charged bilayer lipids in biological systems
[175, 178, 179].
Even if the system of interest is an uncharged lipid bilayer and is stable under excess
water conditions, this technique has another drawback. The coherent and incoherent
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Figure 5.3: Typical saturated salt humidity chamber. Photo courtesy of Thomas Hauß,
V1, HZB.
scattering signals from water are quite strong due to the large magnitude of neutron
scattering lengths from hydrogen and deuterium (see Tables 2.3 and 2.5). Therefore,
allowing the neutron beam to pass through a thick excess water layer results in a poor
signal to noise ratio, as well as in unwanted scattering coming from the water. This
can be avoided by using the bulk water set-up primarily in reflectometry geometry,
allowing the neutrons to pass through a substrate with high transmission (e.g. Si), and
avoiding scattering through water [179].
5.2.2 Saturated salt
Humidity control through a saturated salt solution is one of the most commonly used
techniques. The principle behind this control technique is to limit the amount of water
vapour in a closed container by modifying the exchange rate between liquid water
and water vapour at a reservoir’s surface. The addition of salt to the water reservoir
decreases the probability that water at the surface will dissociate and enter the vapour
phase. To make this technique robust, salt is added until it reaches saturation, forming
a slushy mixture, rather than carefully measuring the salt and water ratio. The desired
chemical potential, and thus relative humidity above the water surface is achieved with
high accuracy (an example of such a humidity chamber is shown in Figure 5.3).
Many different salts have a characteristic humidity associated with their saturated
state and are well characterized in a series of tables [180, 181, 182] (a selection of
commonly used saturated salt solutions is listed in Table 5.1). However, this generates
a non-continuous range of humidity values, with gaps occurring for humidity values
that are not associated with any particular salt. The saturated salt solution technique
is also labour intensive and relatively slow. When setting a new humidity, one must
open an air-tight sample container, carefully clean the reservoir of all salt from the
previous measurement, refill the reservoir with the new salt and wait for the sample
to achieve the new desired hydration. This makes multiple chambers and multiple
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Table 5.1: Relative humidity of commonly used saturated salt solutions at 20, 30, and
40◦C [183].
r.H. at 20◦C r.H. at 30◦C r.H. at 40◦C
LiCl 11.3 ± 0.3 11.3 ± 0.2 11.2 ± 0.2
MgCl2 33.1 ± 0.2 32.4 ± 0.1 31.6 ± 0.1
Mg(NO3)2 54.4 ± 0.2 51.4 ± 0.2 48.4 ± 0.4
NaCl 75.5 ± 0.1 75.1 ± 0.1 74.7 ± 0.1
KCl 85.1 ± 0.3 83.6 ± 0.3 82.3 ± 0.3
KNO3 94.6 ± 0.7 92.3 ± 0.6 89.0 ± 1.2
K2SO4 97.6 ± 0.5 97.0 ± 0.4 96.4 ± 0.4
samples necessary during a time-limited experiment. In particular, when determining
the Fourier phase coefficients of the sample, it is necessary to expose each sample to a
series of different D2O/H2O ratios (minimum three for a centro-symmetric unit cell),
further increasing waiting time, and potentially wasting neutron beam-time.
Since no special infrastructure is used (other than the presence of a water reservoir,
which is also necessary for other techniques), saturated salt can be used in most
humidity chambers. This technique is also suitable for reflectometry experiments, and
the bulk-water chamber from Harroun et al. [179] also uses a saturated salt set-up for
an indirect sample hydration.
Based on the discontinuous accessible humidity range, and the tedious multiple
sample changes necessary while using this technique, it was decided against further
pursuit of this technique for humidity control.
5.2.3 Gas vapour flow
A much quicker variant is the gas vapour flow technique. This technique involves two
mass flow controllers regulating dry and humid gas flow. The two controllers are fed
by a common gas source, typically compressed air or nitrogen, which gets split into two
paths, passes through the mass flow controllers and is then either dried or hydrated.
One gas passes through a desiccant, resulting in a stream of dry gas, while the other
bubbles through water, keeping this stream near saturation. The rate of flow from
each line is controlled by a feedback loop to a humidity sensor located in the vicinity
of the sample. The sample environment then quickly reaches a constant humidity
value, and the sample takes up the water from the atmosphere. Of the non bulk-water
humidity control methods (saturated salt and temperature controlled), gas vapour flow
is substantially faster than the other methods, with the only limiting factor being the
rate at which the sample takes up the water.
The existing gas vapour flow set-ups work reliably for a continuous range of humidity
from very dry (defined by the desiccant, typically ∼ 10 % relative humidity) to
approximately 95% relative humidity [171, 184]. The upper limit arises from two
sources: 1) small temperature gradients in the system, and 2) the range of the best
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a)
b)
Figure 5.4: a) The DMPC lipid bilayer reflectivity bulk-water/saturated salt chamber.
b) First order reflections gathered while using the reflectivity chamber. The
peak shifts to lower-Q (large real-space values) with higher humidity, and
is lost to bulk water. From Harroun et al. [179]
humidity sensors available. Small changes in temperature along the tubes where the
very humid vapour travels result in condensation points. Condensation at a cool point
in the system draws the vapour away from the sample. For example, for a sample at
30◦C close to 100% r.H., a gradient of ∼50 mK can reduce the desired humidity by 3%
(calculated using the Antoine equation 5.1). By insulating the entire set-up against
small temperature variations this can be mitigated. The larger problem comes from
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the performance of available humidity sensors. Of the humidity sensors which are of
suitable size for a humidity sample environment, the measurement uncertainty above
90% relative humidity becomes large. The best resistive or conductive sensors available
are rated to an uncertainty ±2-3% r.H. for the high humidity range. In practice,
above ∼95% r.H., most sensors begin to indicate full saturation, and cannot be used
to regulate a feedback loop.
Although the gas vapour flow method is fast, and provides a continuous range of
accessible humidity, the limitations which exist for the high humidity range have left
only the temperature control technique as a technique worth pursuing.
5.2.4 Temperature control
The relative humidity in a system can also be induced by controlling the partial vapour
pressure through precise control of sample and reservoir temperature [173, 185]. Instead
of keeping the entire system at a fixed temperature and regulating the partial pressure
with a saturated salt solution, a similar effect can be achieved by cooling pure water in
a reservoir and heating the sample. By lowering the temperature of the water reservoir
a lowered partial vapour pressure preservoir is provided to the system, resulting in less
water vapour in the air, as in equation 5.2. The vapour pressure can be determined
directly from temperature using the Antoine equation [186], Equation 5.1, with vapour
pressure p, temperature in Kelvin and A, B, C constants unique to the liquid/gas
system. For water between 1◦C and 100◦C, A=5.402, B=1838.7 (K), C=-31.7 (K)
[187].
log10p = A− B
C + T (5.1)
This method allows a continuous range of relative humidity with the possibility
of fast changes in humidity using temperature controllers. Although the change of
humidity is not as quick as in a gas-flow system, a humidity change is significantly
simpler than the saturated salt technique, as opening and replacing the water is not
necessary. This technique has been used to create chambers which can achieve high
relative humidity, or a range of humidity [173, 185]. The temperature control technique
solves the problem of inaccurate humidity sensors above 95% r.H. by relying instead
on thermometers with high accuracy. The drawback of this method is the requirement
for an environment with extreme temperature homogeneity. As already mentioned in
the gas vapour flow technique, a temperature gradient resulting in a cold spot in an
undesired location creates a condensation point and, in principle, a new water reservoir
of an uncontrolled temperature, typically lower than the desired temperature. However,
an effective insulation of the humidity chamber can significantly suppress the influence
of temperature gradients.
r.H. = preservoir
p∗sample (5.2)
This method allows both mid- and high-humidity to be achieved as well as the
91
5 Humidity chamber as sample environment
advantage of fully automated humidity control, independent of inaccurate humidity
sensors. The one downside to this technique is the fact that small temperature gradients
may make it difficult to reach the highest humidity values, which is a problem faced by
both the gas vapour and temperature control techniques. Great care must be taken to
suppress any cool spots in the chamber.
5.3 Development of the BerILL humidity chamber
With this survey of existing humidity chamber technology, the decision was made
to pursue the temperature controlled humidity control technique. The geometric
limitations (maximum diameter of chamber, dimensions of neutron beam, beam height)
were taken into account, such that the chamber would be compatible with a large range
of diffraction and reflectometry instruments at various neutron scattering facilities.
Slight variations made to this design would also allow compatibility with small angle
and quasi-elastic set-ups.
5.3.1 Initial design
The initial design was sketched out during a meeting at the ILL. The preliminary
design is shown in Solidworks 3D render in Figure 5.5. This design was finalized using
the SolidWorks computer assisted drawing program [188]. Heavy focus was placed on
thermal insulation between three sections of the chamber, to insulate the inner chamber
from the external temperature, and to insulate between the upper chamber (the location
of the sample) and the lower chamber (the location of the water reservoir). Fluctuations
in the external (room) temperature should have no effect on the inner chamber, and
the inner chamber’s upper (sample) section should also be thermally insulated from the
lower (reservoir) section.
An insulating vacuum was used to decouple the inner and outer chambers, with
all connections between the inner and outer chambers made of thermally insulating
material (stainless steel or plastic). These connections are also further shielded by the
chiller channels which circulate tempered fluid through the chamber.
Finite element simulations and modifications to initial design
Before this design was physically produced, a series of finite element simulations were
performed using the COMSOL Multiphysics modelling software [189]. In order to
simulate the equilibrium state of the chamber with a variety of external and internal
temperature conditions, the heat transfer module was used. These simulations were
carried out on the imported Solidworks CAD as well as a simplified radially symmetric
model of the inner chamber. The latter allowed for parametric sweeps of various aspects
of the chamber geometry, while keeping the simulation time reasonable (tens of minutes
rather than hours per parameter change).
The finite element treatment involves separating a geometric problem into
manageable finite elements. For each element (a small volume of the geometry), a
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Water chiller channels 
to define sample 
temperature and 
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between chambers
Aluminum windows 
transparent to 
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accessible angle
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chamber walls to 
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and reservoir areas
Figure 5.5: The first version of the design in Solidworks. Design by M. Barrett, D.
Wallacher and A. Perkins.
set of partial differential equations is solved, ensuring that the boundary conditions of
all neighbouring elements agree, while minimizing the global error function.
In these simulations, Fourier’s law of heat conduction (Equation 5.3) is solved in the
equilibrium case, where q⃗ is the local heat flux, k is the thermal conductivity, A is the
cross-sectional area and ∇T is the spatial temperature gradient.
q⃗ = −kA∇T (5.3)
The first step to a simulation is assigning material properties to each of the chamber
pieces. The density, thermal conductivity and any fixed temperatures are given in this
step. We assumed all surfaces of the chiller channels were fixed temperatures.
Next, the geometry is split into a mesh of finite elements (see Figure 5.6). It is
necessary to make the mesh fine enough to capture small temperature effects, but not
so small that the geometry is over-defined and a simulation takes unnecessarily long to
perform.
With all material properties of the components defined and a working mesh in place,
the simulation calculates the equilibrium temperature of each element of the system. A
series of water reservoir and sample chiller temperatures were simulated, to determine
the influence of different temperatures in the system (from 60%-100% relative humidity
and from 10◦C-40◦C).
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Mesh of inner 
chamber
Cut through chamber 
after eq. temp. simulation
Figure 5.6: A working mesh of the inner humidity chamber (left). Temperature
distribution in a vertical planar cut of the chamber after a simulation (right).
2D rotation constructed in COMSOL 3D construction imported from Solidworks
Figure 5.7: A 2D rotationally symmetric slice (left) is used to recreate the 3D model
(right).
5.3.2 Radially symmetric simplification in COMSOL
The first simulations on a 3D model directly imported from the Solidworks CAD
produced results which made physical sense, but lasted a few hours for each simulation.
The geometry was simplified by recreating a version of the inner chamber directly in
COMSOL (see Figure 5.7), defining all dimensions with equations, relative to other
parts of the chamber. This allowed for geometric parameters to be defined through
mathematical relations, giving the freedom to perform parametric sweeps through
different geometries. The simplified model was a radial slice of the inner chamber,
which is later rotated 360◦ to represent the 3D volume (as shown in Figure 5.7). This
simplification reduced the simulation time to ∼5 minutes per simulation.
The results of a series of temperatures simulated with the radially symmetric
geometry were compared with results from the 3D (SolidWorks imported) simulation
(Figure 5.8), capturing the details of the more complex temperature profile.
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T1
T2
Figure 5.8: A comparison of the temperature from the bottom (d=0 m) to the top
(d=0.16 m) of the inner chamber. The water bath temperature and upper
chiller (T1) were held at 284 K and 298 K, respectively, while the middle
chiller (T2) was varied between 297 K and 316 K. The 2D rotation captures
the trend, with variations due to the simplification of the goniometer and
rotation extrusion of the sample.
A series of parametric studies were carried out to determine what aspects of the
design should be modified or improved: including changing the height of the chamber,
the position of chillers and the shape of the sample post. The most striking modification
was to the position of the T2 (middle) chiller. Having this chiller too close to the lower
edge of the sample substrate (see Figure 5.9) resulted in a loss of the shielding effect
this chiller between the water reservoir and the sample.
On the other hand, positioning the T2 chiller too low caused the water bath surface
temperature to rise (Figure 5.10).
From these parametric simulations, the decision was made to lengthen the chamber
as much as possible vertically, and have the T2 chiller located at the same height as
the goniometer base.
Furthermore, to decouple the upper and lower sections of the inner chamber, instead
of stainless steel (thermal conductivity ∼16 W/(m · K) [190]) as originally planned,
the sample post and gliding seal ring were instead made with PEEK (polyether ether
keytone, thermal conductivity 0.25 W/(m ·K) [191]). This material greatly suppresses
heat transfer from the bottom to the top of the chamber through the chamber walls
and sample post. An additional heater was also included directly underneath the
goniometer, to further shield the goniometer from the water reservoir.
With this series of modifications, the CAD was updated, and another round of
simulations on the imported 3D geometry were performed (see Figure 5.11).
The final drawings were manufactured and the first tests and commissioning were
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Divergence 
begins
Water bath
Sample temperature divergence with T2 chiller position
Figure 5.9: The sample high and low temperature values during a series of simulations
varying the vertical position of the middle chiller (T2). The T2 and T1 (top)
chiller were set to the same temperature (298 K), and the water reservoir
at 283 K. At ∼2 cm above the goniometer base, the shielding effect of the
T2 chiller starts to become less effective, and the maximum and minimum
temperature points on the sample begin to diverge.
Water bath temperature with T2 chiller position
T
Figure 5.10: The water reservoir high and low temperature values during a series of
simulations varying the vertical position of the middle chiller (T2). The
T2 and T1 (top) chiller were set to the same temperature (298 K), and
the water reservoir at 283 K. At the lowest T2 chiller position (2 cm from
the water surface), the water surface temperature diverges by ∼0.5 K.
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a) b)
Figure 5.11: a) The modified chamber design: an elongated upper chamber, insulated
from the lower chamber with PEEK plastic and an additional heater
under the goniometer. b) COMSOL finite elements simulation of modified
chamber, with upper chamber chillers at 286.15 K, water reservoir chiller
at 283.15 K. The temperature difference over the sample is ∼2 mK.
performed in the Fall of 2014 at HZB, and in December 2014 on the D16 diffractometer
at the ILL.
5.4 Commissioning of the BerILL humidity chamber
The parts of the chamber were manufactured by HZB and ILL and assembled in Berlin
(Figures 5.12 and 5.13).
The entire set-up is shown in Figure 5.14. All controllers and sensors were integrated
into a LabView [192] interface prepared by Nico Grimm [193]. The setup is listed below
• 10 Omega high performance thermometers
• 4 Lakeshore 350 temperature controllers [194]
• 2 Kapton heater foils (one below water reservoir, connected via weak-link, one
under the goniometer) to remove thermal fluctuations
• 1 pressure sensor (to check for vacuum leaks)
• 1 humidity sensor (Honeywell HIH-4000, to check humidity equilibration time of
the chamber)
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Figure 5.12: The inner (left) and outer (right) sections of the chamber lid, based on the
design presented in Figure 5.11.
• 2 Julabo Presto A30 temperature control systems [195], regulated by external
thermometers embedded in the chamber
• 1 vacuum turbo pump, for insulation between inner and outer chambers
The tests of the chamber in the neutron beam were done at the ILL on the D16
diffractometer (ILL) and the V1 membrane diffractometer (HZB). Existing humidity
sensors which can fit into a chamber of this size are not accurate at relative humidity
above 95%. This fact necessitates another high humidity observation method. The
dramatic swelling behaviour of lipid membranes at high humidities is an excellent
indicator of relative humidity close to full saturation. This behaviour is well
characterized for commonly used single component lipid bilayers (discussed in detail in
Section 5.1). By observing the shift of peak-position with a diffraction experiment ,
the d-spacing (lamellar repeat distance) can be calculated using Bragg’s law 2.3.
Figure 5.15 shows the 2θ projection (x-axis) of the detector image as it changes in
time (y-axis). The reservoir reaches its temperature setpoint in 30 minutes. One hour
after the set-point was changed, a small fraction of the membrane has reached the
sufficient hydration level to transition to the fluid phase (indicated by the right peak
of the paired Bragg reflections). Four hours after the setpoint change, the majority of
the sample has reached the fluid phase, with only a faint signal from the gel phase
remaining. This phase transition arises from water coming into contact with the
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Figure 5.13: The complete chamber base (left) and the inner section of the chamber
base (right), based on the design presented in Figure 5.11.
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controllers
Vacuum pump
Figure 5.14: The complete humidity chamber set-up.
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head-group section of the membrane. Increasing the hydration between bilayers allows
for the bilayer to fluctuate more. Eventually, enough fluctuations exist that the forces
holding carbon-carbon bonds in the lipid tails in all trans-state give way to “kinks”,
resulting in a smaller d-spacing, and thus higher angle Bragg reflections.
The design allows one to capture the phase transition of the bilayer sample. This gave
us confidence that the physical principle of the chamber works for this type of sample,
and also gave an estimation of the rate which the chamber and sample equilibrate.
It was not, however, possible to observe the extreme swelling which starts to occur
above 98% relative humidity. Due to problems with the insulation vacuum (which could
only achieve 10−3 mbar) and due to temperature gradients, the chamber could reach a
maximum of 95% relative humidity.
5.4.1 Modifications and improvements after the first neutron experiment
A series of modifications on the chamber were performed, including a re-calibration of
all thermometers, better insulation of the tubes running from the Julabo Presto chillers
to the chamber, re-locating the connection between the T1 and T2 chillers inside the
vacuum insulation to avoid a temperature difference between T1 and T2 and improving
the internal gliding seal and the sealing around the piping of the upper chamber.
These improvements removed a difference of approximately 50 mK between the T1
and T2 sample chillers, and resulted in a one order of magnitude improvement in
the vacuum (10−4 mbar). When considering the mean free path of the air molecules
(Equation 5.4) this one order of magnitude improvement has a considerable effect. The
mean free path defines how far a particle will travel before colliding with another, based
on the particle density. A rough calculation shows that from 10−3 mbar to 10−4 mbar
results in a path length change from 6 cm to 60 cm, which is now substantially larger
than the dimensions of the vacuum chamber. Collisions are minimized, and thus heat
transfer from the inner to outer chamber is suppressed.
l¯ = kBT√
2πd2mP
(5.4)
Where l¯ the mean free path length in m, kB Boltzmann’s constant in J/K, dm the
average particle diameter, and P the pressure in Pascals.
A second prototype chamber was produced (BerILL 2.0, Figure 5.16) with a simplified
chamber design and improved sealing is currently in commissioning at the ILL, for
experiments which require an environment up to 98% relative humidity.
5.4.2 Off-line tests and mid-range humidity
Using the BerILL 2.0 prototype, the speed of equilibration of the chamber was
tested off-line for a variety of temperature and relative humidity conditions, in the
mid-humidity range (50%-70% relative humidity) with a calibrated humidity sensor.
Humidity steps of 10% relative humidity were made with the sample at a constant
temperature of 20◦C, by ramping the water reservoir temperature up. The water
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Upper chamber sensors
a)
b)
Water reservoir temp.
gel
fluid
gel
fluid
gel
fluid
Figure 5.15: a) Labview data viewer program showing a sample held at constant 30◦C
and the water reservoir rising from 27.25◦C to 28.75◦C, relating to 85%
and 93% relative humidity. b) Projection of detector image onto 2θ axis,
plotted every minute for 60 minutes starting at 1 hour, 15 minutes after
reservoir temperature change (bottom), and at 4 hours, 5 minutes after
reservoir temperature change (top). The paired peaks are labelled gel or
fluid, accordingly.
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Figure 5.16: The BerILL 2.0 humidity chamber, currently in commissioning at the
Institut Laue-Langevin.
reservoir temperature reaches the desired temperature within ∼10 min., but the
humidity is slower to react. The desired humidity is achieved in 2-3 h, with a slower
response for higher desired humidity (see Figure 5.17).
A similar series of tests was also performed with a constant humidity step (from 60%
to 70% relative humidity) at constant sample temperatures of 20◦C, 40◦C and 50◦C
(see Figure 5.18). Higher sample temperatures resulted in faster response (closer to
2 h), whereas the 20◦C needed ∼3 h to reach equilibrium.
To decrease the time necessary to reach equilibrium, the water reservoir temperature
can be overshot. A series of tests were performed to see the effect of overshooting the
temperature (see Figure 5.19). This can be useful for experiments when the sample is
robust, to bring the sample to equilibrium in a short amount of time. The equilibrium
humidity condition can be reached in as little as ∼1 h.
It is important to note that the response of the chamber may not be a good indication
of the response of the sample. Lipid samples may react much slower than the chamber
itself. For experiments with the humidity chamber, one should ensure that the sample
itself has reached an equilibrium before starting a measurement.
The HZB version of the chamber (BerILL 1.0) is available for user service at the
time of writing this thesis. The first users have already successfully measured graphene
monolayers under varying hydration levels through humidity on the V1 diffractometer
in the 30% to 90% relative humidity range.
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Humidity response to bath temperature change (20°C sample)
Figure 5.17: Humidity steps of 10% relative humidity, with a constant sample
temperature of 20◦C. It takes ∼2-3 h to reach the desired humidity
equilibrium.
5.4.3 High humidity range
Both prototypes were tested again at HZB and ILL on V1 and D16, respectively.
With the improvements which were made, a maximum d-spacing of only ∼52.3 Å
could be achieved in a DMPC sample at 30◦C (see Figure 5.20) relating to ∼99%
relative humidity, even with the water reservoir and sample set to the same temperature
(nominal 100% r.H.).
Three hypotheses were developed to explain the upper limit of 99% relative humidity
shown in Figure 5.20.
• An unknown cold point in the chamber was preventing the vapour from reaching
the sample (the difference between 99% and 100% relative humidity at 30◦C is
only 170 mK (Equation 5.1))
• The massive brass goniometer containing many small channels and moving parts
is acting as a porous system, the water is drawn first to the goniometer before
the sample
• A lack of temperature gradient between the bottom and top sections of the
chamber causes the air to remain stationary, no vapour exchange between top
and bottom of inner chamber
The thermometry in the system does not indicate such a drastic cold point, although
due to difficulties in measurement on non-conductive materials (plastic insulation)
there may be an effect present. It has been shown by other groups attempting to
achieve high humidity that vertical samples are difficult to deal with, due to slight
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Humidity response to bath temperature change (60 70% r.H.)
Figure 5.18: Humidity steps from 60% to 70% relative humidity at constant sample
temperature of 20◦C (blue), 40◦C (green) and 50◦C (pink).
gravitational effects. This is unavoidable, as the neutron instruments for which this
humidity chamber will be used are all vertical sample geometry.
With these hypotheses in mind, a high-humidity sample holder was developed, to
reach the remaining 1% humidity level and achieve 100% humidity on the sample.
5.4.4 High humidity sample holder
A high humidity sample holder was designed for achieving humidities above the 98%
level. This sample holder is used in place of the standard goniometer. A Peltier element
is mounted on the sample holder to provide local cooling directly on the sample’s
substrate. By cooling the substrate, the water vapour is drawn to the sample. The
high humidity sample holder can be seen in Figure 5.21. The sample holder is made
primarily of aluminum, allowing fast thermal equilibration. A post made of PEEK
plastic is used for mounting, which instills thermal insulation between the sample and
the reservoir.
The Peltier elements work via the thermoelectric effect, an applied voltage across
a thermoelectric device that creates a temperature difference. In our sample holder,
two Peltier elements are clamped between two thermally decoupled massive aluminum
blocks. The aluminum block in which the sample is mounted is in contact with the cold
side of the Peltiers, and the heat-exchanger is in contact with the hot side. Two thick
copper wires create a bridge between the heat-exchanger and the copper block under
the sample holder. This copper block is in good contact with the T2 chiller, connected
with four copper wings. The high flux of the Julabo chillers is enough to compensate
for the small amount of heat the Peltier creates. The heat exchanger acts to remove
the heat from the proximity of the sample, otherwise the air around the sample will
heat faster than the Peltier can remove heat. In this setup, the Peltier can run with
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Humidity response to bath temperature overshoot
 (20°C Sample, 50 60% r.H.)
Figure 5.19: Humidity steps from 50% to 60% relative humidity with a constant sample
temperature of 20◦C. By overshooting the water reservoir temperature, the
equilibrium rate of the chamber is decreased.
a maximum of 0.35 W (higher than this power will produce more heat than can be
removed by the heat-sink bridge).
For these experiments, a DOPC bilayer sample was used instead of the DMPC used
up to this point. This choice was made as DOPC begins drastic swelling at a lower
humidity, allowing us to characterize the swelling more precisely (see Figure 5.2).
The DOPC bilayer swells drastically with the Peltier addition, up to 64 Å, the
theoretical hydration d-spacing maximum of DOPC (see Figure 5.23). At this point in
time, a peak splitting above 59 Å occurs (relating to ∼99.9% relative humidity) seems
to indicate two domains in the sample, resulting in two defined d-spacings. This may
arise from operating the two Peltier elements as if they were exactly identical. If the
internal resistance of one Peltier is slightly lower, it would be possible that the top of
the sample is cooled a few mK more than the bottom, causing this phase separation.
Further tests are in progress at V1 at HZB to determine the cause of this behaviour
and to test possible solutions.
5.5 Notes
• This project has received funding from the European Union’s 7th Framework
Programme for research, technological development and demonstration under the
NMI3-II Grant number 283883.
• A manuscript containing this work is currently in preparation.
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Figure 5.20: Hydration run on V1 diffractometer, HZB. DMPC sample at 30◦C.
The d-spacing of the sample is calculated through the Bragg equation
(Equation 2.3), and relates to a humidity range of ∼97% to ∼99% relative
humidity (see 5.2). The inset shows the swelling of the bilayer pictorially,
the water layer is exaggerated for clarity.
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Figure 5.21: CAD of the high humidity sample holder (left) and the holder mounted
inside the BerILL 2.0 chamber (right). Although it is compatible with
both the HZB BerILL 1.0 and the ILL Berill 2.0 humidity chambers.
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Peltier elements 
(behind heat 
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Figure 5.22: High humidity sample holder mounted onto chamber base. Peltier
elements are clamped between the sample mount and heat-exchanger.
Heat exchanger forms a thermal bridge to the T2 chiller through two thick
copper wires and four copper wings, removing heat from the warm side of
the Peltier elements.
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Figure 5.23: Bragg reflections from a DOPC lipid bilayer at 20◦C. Calculated d-spacings
of each measurement are shown, relating to 99.6% to 99.99% relative
humidity. Above a d-spacing of 59 Å splitting occurs, which may indicate
two domains in the sample.
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6.1 Summary
The experimental work described in this thesis involved both structural and dynamical
measurements of model lipid membranes and the changes induced by a selection of
amyloid-β peptides.
Tagged A 22-40 
localized in the bilayer
Lipid dynamics with 
A 22-40 slowed at 30°C
a) b)
Figure 6.1: a) The position of amyloid-β22−40 peptide in the lipid bilayer was
determined through neutron diffraction experiments with lipid bilayers
containing deuterium tagged peptides. b) The dynamics of lipids over
a picosecond to nanosecond time-scale and the dynamic perturbations
induced by a peptide have been characterized. At 30◦C, the presence of
the peptide causes slowing of lipid dynamics which have assigned to the
lipid centre of mass diffusion and lipid tails.
In Chapter 3, experiments were performed on anionic lipid bilayers consisting of
DMPC and DMPS lipid model membranes to localize a small molar amount (1.5 mol%)
of the peptide amyloid-β22−40, determine what structural changes this peptide induces
in the membrane and finally determine how the presence of this peptide perturbs lipid
dynamics spanning time-scales from picoseconds to nanoseconds. Figure 6.1 presents
graphically both of these results.
For the first time, evidence was presented which indicates the amyloid-β22−40
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peptide intercalates into the lipid membrane and in doing so increases the lipid bilayer
d-spacing. With the knowledge of the peptide location in the lipid bilayer, quasi-elastic
neutron scattering experiments with this particular peptide fragment using a range of
instrumental resolutions (and thus a broad time-range) were performed. This was the
first experimental evidence published revealing the dynamics of lipid bilayers affected
by peptides over such a broad time-scale, relating to lipid dynamical processes including
whole molecule diffusion, lipid chain dynamics, and localized vibrational motions.
These measurements reveal that 1.5 mol% of the peptide can induce changes in the lipid
dynamics over multiple time-scales, with increased diffusion coefficients in the gel-phase,
and decreased diffusion coefficients reported near the phase transition. This type of
perturbation of lipid bilayer dynamics has been seen in lipid bilayers containing low
concentrations (∼5 mol%) of molecules including cholesterol and sodium glycocholate
(a surfactant used to emulsify fats and enable absorption in the digestive system) [81].
More recently a publication from Sharma et al. (July 2015 [33]), in which a very low
concentration (0.2 mol%) of melittin peptide was added to DMPC vesicles, presents
results on lipid dynamics in the nanosecond regime which reflect very closely the findings
presented in this thesis.
A 22-40 localized in 
cholesterol rich bilayers
a) b)
A 1-42 localized in 
cholesterol rich bilayers
Figure 6.2: a) The locations and orientations of an amyloid-β22−40 peptide fragment
in cholesterol rich (≥30 mol% cholesterol) bilayers were determined using
X-ray diffraction experiments. A two population model, with a surface
and embedded peptide best fit the experimental results. b) The locations
and orientations of an amyloid-β1−42 peptide in cholesterol rich (≥30 mol%
cholesterol) bilayers were also determined. A single peptide model was
sufficient to describe the electron density differences at 40 mol% cholesterol.
In Chapter 4 an anionic membrane containing cholesterol has been measured with
both the amyloid-β22−40 fragment (as was used in Chapter 3) and the full-length
amyloid-β1−42. The effect of the cholesterol on the bilayer structure with and without
the peptide was tested, and the location of the peptide was modelled in membranes
below and above the cholesterol saturation limit in the bilayer. Evidence was presented
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which shows that both of the peptides intercalate into the bilayer, and have a substantial
effect on the membrane structural parameters. This is the first systematic study of the
influence of cholesterol and these amyloid-β peptides on the membrane structure.
High relative humidity
Low relative humidity
Figure 6.3: BerILL humidity chamber with supported lipid multilayer sample. The
chamber allows for the humidity to be regulated to high accuracy and with
fast equilibration times. In the case of a lipid membrane multilayer sample
(represented by a single layer in the box), the repeat distance between low
(≤90%r.H.) humidity and high (≥98%) humidity swells a dramatic 10 with
water recruited to the region between lipid head-groups.
Finally, in Chapter 5, the development and commissioning of a new humidity and
temperature sample environment for neutron experiments is presented. The BerILL
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humidity chamber (Figure 6.3) now exists in two working prototypes located at the
Helmholtz-Zentrum Berlin and the Institut Laue-Langevin, and has seen the first user
service in September 2015. This chamber allows for more efficient experiments on
biological samples (like the model membranes presented in this thesis) as well as other
humidity/hydration sensitive materials.
6.2 Outlook
The structural measurements of peptides in cholesterol-rich model membranes
presented in Chapter 4 set the stage for lipid dynamic studies of the same system.
These structural results indicate that both the fragment amyloid-β22−40 and the
full-length amyloid-β1−42 intercalate into the cholesterol rich membrane, and cause
substantial structural changes. Dynamical studies of this system would lead to a
better understanding of the relationship between the structural changes induced by
the peptide and the dynamical processes which the lipids in the bilayer undergo.
In the melittin-membrane system discussed previously (by Sharma et al. [33]) the
centre-of-mass lipid diffusion was studied in a lipid bilayer, with results reflecting the
amyloid-β22−40 results presented in this thesis, but also with cholesterol-rich bilayers
(20 mol% cholesterol). In the cholesterol-rich samples, no detectable change was
observed in membranes with and without the melittin peptide. It is thus an exciting
and logical next step to perform quasi-elastic neutron scattering on samples containing
peptides which interact with cholesterol-rich bilayers.
A step further towards physiological relevance especially with respect to Alzheimer’s
disease would involve determining the effect of amyloid-β peptides on natural
membranes. Experiments on model membranes provide valuable first steps, and
an understanding of important physical processes, but lack many of the important
complexities which natural membranes contain. An ideal candidate in these
experiments would be using membranes of mitochondria. The mitochondria organelle is
responsible for production of adenosine triphosphate (ATP), which is required to carry
out synaptic processes and to produce neurotransmitters. Mitochondria are found in
high concentration near the synapses of neuronal cells, where this ATP is used in large
quantities. Experiments on mitochondrial membranes would allow one to test if the
effects observed in model membranes can be translated to natural systems.
Experiments on model lipid membranes in very high humidity ranges are also now
possible with the use of the BerILL humidity chamber. Experimental conditions which
were unstable or inaccessible previously are now within the range of experimental
feasibility. As well as extreme humidity conditions, diffraction experiments with
moderate humidity ranges will be more efficient, determination of phase coefficients
can be performed through swelling of the bilayer, rather than opening the chamber to
replace the D2O:H2O ratio of the water reservoir.
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